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Abstract 
SEX-DEPENDENT ROLE OF INTERLEUKIN-1 SIGNALING IN EMOTIONAL AND 
COGNITIVE BEHAVIORS IN MICE:  PHENOTYPING MALE AND FEMALE 1L1-R1 
NULL MUTANT MICE 
by 
Jennifer A. Johnson 
 
Adviser:  Adjunct Associate Professor Susan D. Croll 
IL1-R1 null mutant mice (IL1-R1 KO) have reduced signaling in the interleukin-1 (IL-1) 
pathway, making them a convenient model for testing the importance of IL-1 in either the 
development or maintenance of mouse behaviors.  Prior research has revealed impaired cognitive 
and emotional processes in adult male IL1-R1 KO mice, including impaired spatial learning and 
memory and decreased anxiety with associated impairments in hippocampal cell proliferation 
and signal transmission.  The current studies explored the neuroanatomy and behavioral 
phenotype of both male and female IL1-R1 KO mice.  An array of behavioral tests was 
administered, including retesting at an older age for cognitive and emotional behaviors.  Animals 
were sacrificed and their brains were measured for neuroanatomical abnormalities, cell 
population densities, and vascular proliferation.  The results were consistent with prior findings 
of impaired spatial learning and memory performance for male IL1-R1 KO animals, as well as 
reduced anxiety-type responses in multiple behavioral tests.  Female IL1-R1 KO mice were less 
affected, and showed no behavioral impairment in the Morris Water Maze (MWM).  The 
findings also revealed an increased depressive-type behavior in the Porsolt Forced-Swim test 
 v 
(FST), but only in female IL1-R1 KO animals.  All animals were retested at a later age in the 
MWM to determine if the observed sex-based differences in impaired spatial learning and 
memory would persist or increase with age.  We found impaired spatial memory performance for 
aged IL1-R1 KO animals, and although older male KOs showed poorer performance in the 
MWM than female KOs, the difference between sexes no longer achieved statistical significance.  
Neuroanatomical evaluation revealed no gross differences in cortical or hippocampal structure.  
However, IL1-R1 KO animals had significantly reduced vascular investment in the hippocampal 
region, a finding that significantly correlated with impaired spatial memory performance in older 
animals.  These findings suggest that disruption of normal IL-1 activity can influence vascular 
density in the hippocampus and also alter hippocampally-mediated behavior, including spatial 
learning and memory.  The findings also reveal sex-dependency of these effects, suggesting the 
possibility that male and female animals suffer different behavioral consequences of IL-1 
signaling deficiency. 
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CHAPTER 1:  GENERAL INTRODUCTION 
Interleukin-1 
Interleukin-1 (IL-1) is a pro-inflammatory cytokine important for the physiological 
immune response.  Cytokines like IL-1 are proteins important in immune functions, but many 
have also been found to be important in the signaling between neurons and glial cells of the 
central nervous system.  Many cytokines, including IL-1, are also important for embryonic 
development and neuro-developmental processes.  The two forms of IL-1, IL-1α and IL-1β, exert 
their effects on Type I (IL-1R1) and Type II (IL-1R2) receptors.  Generally, IL-1α has a higher 
affinity to bind with IL-1R1, while IL-1β has a higher affinity for IL1-R2, though both IL-1α and 
IL-1β will bind to either receptor.  The IL1-R2 receptor acts as a decoy receptor, producing no 
signal when either IL-1α or IL-1β is present.  In addition, IL1-R1 antagonist (IL-1ra), a naturally 
occurring antagonist, has a very strong affinity for IL1-R1, but does not transduce a signal at the 
IL1-R1 receptor.  The presence of IL-1ra and the decoy receptor function of IL1-R2 mean the 
primary signaling pathway of the IL-1 system is associated with binding of IL-1β to IL1-R1 (see 
Dinarello, 1997, for a review). 
IL-1 activity is diffusely distributed throughout the central nervous system, with 
especially high expression in regions associated with neurogenesis and/or plasticity.  
Specifically, IL1-R1 is highly concentrated in the olfactory bulb, frontal cortex, hippocampus, 
thalamus, hypothalamus, and cerebellum (Gayle, Ilyin, & Plata-Salamán, 1997).  It is widely 
accepted that IL-1 is highly active in the central nervous system, with consistent findings of 
especially high expression in the hippocampus (Ross, Allan, Rothwell, & Verkhratsky, 2003), 
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which has been associated with neuroplasticity and learning and memory processes (Moore, Wu, 
Shaftel, Graham, & O’Banion, 2009; Murray & Lynch, 1998). 
Normally, only trace amounts of IL-1β are found in the adult central nervous system 
(CNS).  IL-1β levels are found to spike with the presence of a pathogen (Fontana, Weber, & 
Dayer, 1984) or CNS insult (Giulian, Chen, Ingeman, George, & Noponen, 1989).  IL-1 activity 
increases with many different pathological conditions, including injuries to the central nervous 
system, as well as local or peripheral injuries, and has been associated with activation of glial 
cells, including both astrocytes and microglia (the brain’s specialized resident macrophages) (see 
Basu, Krady, & Levinson, 2004, for a review).  The purpose of IL-1 activation in the injured 
central nervous system is under dispute (Gosselin & Rivest, 2007).  Early on, evidence indicated 
IL-1 was important in the healing process, through the activation of glial cells, neuronal 
sprouting, promotion of vascularization, and production of neurotrophic factors.  More recently, 
however, evidence for other more constitutive effects of IL-1 has accumulated.  This evidence 
will be described at length in later sections of this review. 
In the periphery, IL-1β is secreted into the bloodstream, where it triggers fever 
production through activation of the hypothalamic vascular network, as well as activation of 
endothelial receptors throughout the body (Schöbitz, Reul, & Holsboer, 1994).  Because of its 
strong role in the immune response, it is not surprising that IL-1 has been found to play an 
important role in inflammatory and autoimmune disorders (see Blanco, Palucka, Pascual, & 
Banchereau, 2008, for a review), including gout and rheumatoid arthritis (Pope & Tschopp, 
2007; Brennan & McInnes, 2008; & García-De La Torre & Nava-Zavala, 2009).  However, IL-1 
has also been associated with the promotion of neuronal damage in the acute stages of injury, 
perhaps via its promotion of free radicals (Betz, Schielke, & Yang, 1996).  In addition, by 
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upregulating glial cell activity, IL-1 is also implicated in neuro-degenerative diseases (Giulian, 
Vaca, & Johnson, 1988).  One example is Alzheimer’s disease (AD), in which microglia are 
found to surround amyloid plaques, and possibly play a role in the development of the plaques, 
or at least in the immune response to the plaques (Shaftel, Griffin, & O’Banion, 2008).  Via these 
same mechanisms, IL-1 has also been suggested as a player in demyelinating diseases (see 
Viviani, Gardoni, & Marinovich, 2007). 
IL-1 is an important player in a cascade of immunological processes associated with 
infection and the fever response (see Basu et al., 2004, for a review).  During the peripheral 
immune response, sentinel cells (macrophages, leukocytes, and mast cells) detect a pathogen, 
signaling the release of cytokines that are carried to the brain via the bloodstream or reach the 
brain indirectly via nerves (e.g., the vagus nerve) (Gabay, Smith, Eidlen, & Arend, 1997).  
Several cytokines are known to trigger the metabolic and behavioral changes seen in the sickness 
response, promoting disease resistance and recovery processes (see Tizard, 2008, for a review).  
The biggest players in this cytokine response include IL-1β, tumor necrosis factor alpha (TNF-
α), and Interleukin-6 (IL-6).  Additional cytokines have also been associated with the sickness 
response, including Interleukin-18 (IL-18), Interleukin-33 (IL-33), high mobility group box 
protein-1 (HMGB1), and Interferon-γ (IFN-γ).  Thus, while the current paper focuses specifically 
on IL-1, it is recognized that it is only one element in a very complex innate immune system. 
Interleukin-1 and Sickness Behavior 
As a proinflammatory cytokine, IL-1 is known to play an important role in the normal 
immune response and related “sickness behavior.”  During the normal immune response to 
pathogens people will develop a fever and associated transient changes in behavior, mood, and 
cognition.  The typical sickness response includes an anorexic response, with reduced feeding 
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and drinking as well as weight loss (Szelenyi & Szekely, 2004).  Individuals will also experience 
a general malaise and depression, accompanied by social withdrawal, decreased sexual activity, 
anhedonia, fatigue, and changes in sleep, including a marked increase in slow-wave sleep 
activity (Vollmer-Conna, et al., 2004; Krueger, 2008; Eisenberger, Inagaki, Mashal, & Irwin, 
2010).  In some cases of sickness behavior, people may experience enhanced perception of pain 
and feelings of muscle weakness.  In addition to these physical and emotional symptoms, 
sickness behavior may also include cognitive changes, including impaired learning and difficulty 
concentrating (see McAfoose & Baune, 2009, for a review). 
It is hypothesized that both the thermoregulatory changes and the related changes in 
behavior have a biological value, by promoting the conservation of limited physiological 
resources and recovery of energy homeostasis (Engel & Schmale, 1972; Dantzer, 2001).  
Because of the complexity of the immune response, the changes can be transient or have a more 
long-term systemic effect, especially for the more severe emotional and cognitive changes 
(Szelenyi & Szekely, 2004). 
While widely recognized, systematic research into the wide array of motivational, motor, 
emotional, and cognitive behavioral changes associated with the febrile response are limited.  In 
fact, most studies of multi-domain changes in humans with the sickness response have focused 
on specific clinical conditions and related treatments that regulate cytokine activity, but have 
failed to either focus on a broad array of symptoms or to link the changes directly to measured 
cytokine activity.  For example, Santoro, Tomita, and Larson (2007) focused on emotional 
changes (increased depression and anhedonia) and cognitive symptoms (impaired learning, poor 
concentration, and decreased attention) that systematically fluctuated with periods of illness 
flares in patients with systematic lupus erythematosus (SLE), but failed to document the direct 
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correlation to cytokine levels or other changes in sickness behavior.  Also, the connection 
between the proinflammatory response to chemotherapy and cognitive impairments has been 
anecdotally documented, and recently validated in a clinical study (Myers, Sousa, & Donovan, 
2010).    
A cluster of disorders known as CAPS (cryopyrin-associated periodic syndrome) has 
provided a strong link between IL-1 activity and sickness behavior.  CAPS includes three 
overlapping inherited disorders, each of which involves chronic of recurrent systematic 
neuroinflammation of the skin, muscles, skeleton, joints, eyes and CNS (see Giat & Lidar, 2014, 
for a review).  Patients with the most severe of the CAPS disorders, neonatal onset multisystem 
inflammatory disorder (NOMID), will also frequently develop hydrocephalus or brain atrophy, 
accompanied by sensorineuroal hearing loss and mental retardation.  Recently, three different 
anti-IL-1 treatments have been developed for the alleviation and even complete remediation of 
symptoms, with varying results for patients with the more severe NOMID condition (Goldbach-
Mansky, 2011; Neven et al., 2009).    
Finally, studies of a common anti-inflammatory treatment for multiple sclerosis (MS) 
have shown in one instance the induction of a physical sickness response without emotional or 
cognitive symptoms in healthy individuals injected with Interferon-β-1b (IFN-β-1b) (Exton, 
Basse, Pithan, & Goebel, 2002), while MS patients on a regimen of weekly treatments of 
Interferon-β-1a (IFN-β-1a) were found to reduce their rate of progression of cognitive 
impairments within two years (Patti et al., 2009). 
Notably, most clinical studies have focused on conditions that result in a long-term 
inflammatory state that can result in neuronal damage, which is not typically found in the acute 
inflammatory response (Teeling & Perry, 2009).  More comprehensive studies of acute and 
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systemic sickness behavior have been conducted in animal populations, typically inducing a 
sickness response either with central or peripheral administration of a pathogen that produces a 
cytokine response or with direct injections of cytokines.  Injections of lipopolysaccharide (LPS), 
even at very low doses, produce a series of behavioral changes, including reductions in 
locomotion, grooming behavior, rearing, and social interactions in rats (Bison, Carboni, Arban, 
Gerrard, & Razzoli, 2009).  The array of behavioral changes associated with cytokine activity is 
broad.  Peripheral injections of IL-1β or LPS elicit an anorexic response, accompanied by weight 
loss within a day of injection (Bison et al., 2009; Harden et al., 2011).  In addition, animals are 
found to develop a conditioned taste aversion with IL-1 injections (Tazi, Dantzer, Crestani, & Le 
Moal, 1988), while blocking IL-1 receptors prevents the anorexic response to LPS injections 
(Rothwell & Luheshi, 2000). 
Fatigue is typically measured in animal research by a decrease in locomotor, grooming, 
and exploratory behaviors, as well as an increase in sleep activity.  Injections of IL-1β not only 
increase sleep activity, but specifically lead to increased proportion of sleep time spent in non-
REM sleep (Yasuda, Yoshida, Garcia-Garcia, Kay, & Krueger, 2005), though very high doses of 
IL-1β can decrease sleep activity (Opp, Obal, & Krueger, 1991).  Conversely, mice treated with 
IL-1ra, blocking IL-1β activity, were resistant to development of a fever or sickness behaviors 
when later injected with IL-1β (Cremona, Goujon, Kelley, Dantzer, & Parnet, 1998).  Similarly, 
IL1-R1 knock out (KO) mice injected with turpentine fail to have the typical acute phase 
response to inflammation, including reduced lethargy, a loss of the anorexic response, and 
preserved body weight (Leon, Conn, Glaccum, & Kluger, 1996).  In addition, adult female IL1-
R1 KO animals have been found to have slightly altered circadian rhythms, with slightly reduced 
activity during light cycles and slightly increased activity during dark cycles (Murray, Obiang, 
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Bannerman, & Cunningham, 2013).  Unfortunately, male animals were not included in this 
measure.  IL-1α/β KO mice have also been shown to lack a typical febrile response and related 
decreases in locomotion following a surgical procedure that induced an HPA (Hypothalamic-
Pituitary-Adrenal) stress response (Furuzawa, Kuwuhara, Ishii, Iwakura, & Tsubone, 2002). 
The amelioration of the sickness response is not specific to IL-1.  This effect can occur 
when either IL-6 or IL-1β activity is blocked (Harden et al., 2011).  Specifically, blocking the 
activity of IL-6 prevented an increase in body temperature (fever response), along with an early 
reduction in food intake and more long-term effects (24 hours) on immobility.  On the other 
hand, blocking IL-1β activity only mildly reduced the fever response, but had a significant 
impact on sickness behaviors.  In addition, blocking one cytokine or the other failed to affect the 
expression of their counterpart, indicating that while both cytokines are involved in the 
production of a fever and related sickness behavior, they are not dependent on one another for 
normal levels of activity. 
In addition, pathogenic stimuli cause an activation of multiple different actions, as 
evidenced by the separate contributions of IL-6 and IL-1 on sickness behavior.  Thus, it is not 
surprising that research findings on fever induction and sickness behavior have been 
contradictory.  In particular the effects of isolated injection of IL-1β will differ from effects 
associated with a more complex immune response following a natural pathogen, such as LPS. 
Bluthé et al. (2000) found that IL1-R1 KO mice had a reduced sickness behavior response to 
both central and peripheral injections of IL-1β, but not to centrally administered LPS.  The 
difference in these effects was found to potentially depend on the upregulation of TNF-α with 
LPS injections, which effectively replaced the deficient IL-β activity, as evidenced by a similar 
reduction in sickness behavior when animals were given a TNF-α blocking agent. 
  
8 
8 
The specific role of IL-1β in the inflammatory response associated with fever and 
sickness has also been found to vary over time, with evidence for two phases of IL-1β induction 
(Konsman, Kelley, & Dantzer, 1999).  In the acute phase, approximately two to four hours after 
peripheral LPS injections, IL-1β production peaks in the circumventricular organs, choroid 
plexus, and cerebral vasculature.  Approximately eight to twelve hours after LPS injections, a 
second peak occurs, involving microglial cells.  The difference in these two phases of IL-1β 
upregulation has been hypothesized to lead to an initial sickness behavior in the early stages of 
infection, and depressive symptoms in later stages of infection and chronic inflammatory 
conditions (Dantzer, 2001).  These findings are important for animal studies of sickness 
behavior, as there is a large degree of overlap in behavioral patterns between the lethargy 
associated with illness and the malaise associated with depression, which is frequently 
experienced with a prolonged illness.  Support for this theory comes from findings that LPS 
injections produce a reduction in mobility two hours later, which coincides with increases in IL-
1β, IL-6, and TNF-α levels in the hippocampus, striatum, and frontal cortex, while at the 24-hour 
mark, animals instead show a depressive response in the Porsolt forced-swim test (FST), which 
is accompanied by a an even greater increase in IL-1β levels, centrally, while IL-6 and TNF-α 
levels return to normal levels (Bay-Richter, Janelidze, Hallberg, & Brundin, 2011). 
Interleukin-1 and Stress 
During an acute stressful event the HPA (Hypothalamic-Pituitary-Adrenal) axis is 
activated, starting with the hypothalamus-triggered release of ACTH (adrenocorticotropic 
hormone) from the pituitary gland that stimulates corticosteroid synthesis and secretion from the 
adrenal gland.  Glucocorticoids, in turn, travel back to the hypothalamus and pituitary gland and 
suppress the production of ACTH (see Laugero, 2001, for a review).  This negative feedback 
  
9 
9 
loop is important for the regulation of the acute stress response.  Glucocorticoid receptors are 
also found in the hippocampus, as well as the septum, amygdala, and other cortical and 
subcortical regions (Reul & de Kloet, 1985; van Eekelen, Kiss, Westphal, & de Kloet, 1987; 
Joëls, 2001).  Thus, the stress response can have a widespread effect within the CNS. 
Cortisol, a glucocorticoid, is a major stress hormone that can be harmful in severe stress 
or chronic stress conditions, with evidence of stress-induced atrophy in the hippocampus in both 
humans and animals (see Bremner, 2006, for a review).  This atrophy can, in turn, affect memory 
performance.  The link between stress, anxiety, and cytokine activity is well established in 
clinical and non-clinical populations.  Individuals in good health undergoing a significant 
emotional stressor will frequently report depressive symptoms and anxiety, which are associated 
with a proinflammatory response.  For example, Maes et al. (1998) found medical students had 
increased levels of multiple proinflammatory cytokines the day prior to taking an academic 
exam, and individuals who reported the most severe anxiety symptoms were found to have the 
highest levels of proinflammatory cytokines.  It has even been found that individuals undergoing 
a mild cognitive stressor (e.g., mirror drawing and color-word interference Stroop tasks) had an 
increase in IL-1β gene expression, and this increase correlated with measures of sympathetic 
nervous system activity, including increased blood pressure and heart rate (Brydon et al., 2005). 
Given that HPA axis activation leads to increased sympathetic arousal, including 
increased blood pressure, it is not surprising that individuals with high levels of chronic 
psychosocial stress are at an increased risk for coronary heart disease.  These high-risk 
populations are also found to have a systemic inflammatory condition (Kuper, Marmot, & 
Hemingway, 2002; Shen, Chen, & Ge, 2004).  For example, von Känel, Bellingrath, and 
Kudielka (2009) found teachers reporting career burnout had relatively high levels of 
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proinflammatory cytokines, including a surge in TNFα levels.  This population was also found to 
be at a higher risk for developing cardiovascular disease.  Similarly, post-combat post-traumatic 
stress disorder (PTSD) patients were found to have higher IL-1β serum levels that correlated 
with the duration, but not severity, of anxiety symptoms (Spivak et al., 1997). 
While the HPA axis plays a role in the suppression of the immune system, the immune 
response can influence HPA activity.  For example, IL-1β stimulates the release of corticotropic-
releasing factor (CRF) by the hypothalamus, which, via ACTH, induces the secretion of 
glucocorticoids from the adrenal glands (see Laugero, 2001, for a review).  This feedback loop 
between HPA activity and cytokine activity has also been associated with changes in emotional 
behavior.  Mice injected with IL-1 show activation of the HPA axis, which is associated with 
increases in noradrenaline and serotonin (5-HT), both of which are implicated in depressive and 
anxiety conditions (Dunn, 2000).  The relationship between IL-1β and HPA axis activation is 
very complex, with the time course and overall impact varying with the types of injections given 
(intraperitoneal vs. subcutaneous) (Dunn, 2000), or the type of anxiety-provoking stimulus that is 
used (Plata-Salamán et al., 2000). 
Multiple models have been developed to induce a stress response in rodents, eliciting 
behaviors that are categorized as either depressive or anxiety-like.  The distinctions between 
anxiety and depression are especially important in animal models of behavior.  Cryan and 
Holmes (2005) propose that while there is a large degree of heterogeneity for depressive and 
anxiety conditions, behavioral testing has developed to focus on the differences in these 
conditions.  Generally, testing of depressive behavior focuses on coping, learned helplessness, 
anhedonia, and social interactions.  Anxiety tests tend to focus more on approach and exploratory 
drives.  Frequently, both depressive and anxiety behavioral testing will employ the use of a stress 
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stimulus, which can have effects on both depressive and anxiety-type behaviors.  The validity of 
these different stress-based tests in eliciting anxiety and or depressive responses has been 
confirmed repeatedly with the alteration of responses following the introduction of anxiolytic or 
antidepressant medications (see Belzung & Griebel, 2001, and Cryan & Holmes, 2005, for 
reviews). 
Early tests of anxiety in response to a stressful stimulus were based on conditioning 
paradigms, in which animals were conditioned to expect a fearful and often painful stimulus 
(e.g., foot-shock).  Another set of tests measure exploratory behavior in novel settings, such as 
the elevated plus maze in which an animal is placed on a cross shaped platform with two arms 
that are closed and an opposing set of exposed arms (Belzung & Griebel, 2001).  Anxious 
animals will typically avoid entering the open, exposed arms.  Similarly, in the open field test 
animals are placed in a large grid with walls on all four sides, and animals high in anxiety will 
tend to spend their time exploring along the wall edges instead of entering the open, exposed 
center of the grid. 
Additional tests measure more trait-based anxiety, as opposed to an acute stress response.  
In the marble burying task, animals are placed in a cage with several marbles placed on top of 
the bedding (Nicolas, Kolb, & Prinssen, 2006).  Animals with a trait anxiety similar to that of 
patients with Obsessive Compulsive Disorder (OCD) are found to bury the marbles in the 
bedding.  Tests of social neophobia (avoidance of an unfamiliar, non-threatening animal) are also 
thought to measure more chronic trait-type anxiety (Belzung & Griebel, 2001). 
Finally, another set of tests look at the effects of more chronic stressful conditions and 
effects on behavior.  In the chronic unpredictable stress (CUS) paradigm, animals are exposed to 
alternating mild (e.g., wet bedding or tilted cage) or moderate (e.g., predator in nearby cage) 
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stressors over the course of several weeks, followed by testing of anxiety-like behavior (Bondi, 
Rodriguez, Gould, Frazer, & Morilak, 2008).  More recently, in an attempt to develop a more 
ecologically valid model of chronic stress exposure, researchers have employed a chronic social 
defeat test, in which animals are paired repeatedly with another animal, allowing for the natural 
response of dominant and aggressive behavior (Denmark et al, 2010).  After repeated 
experiences of social defeat, animals are then tested in measures of anxiety-type behavior. 
Much of the research into the relationship between IL-1β and anxiety-type responses to 
stressful experiences has employed the use of the elevated plus maze and open field test.  
Animals injected with IL-1β are found to have anxiety-type responses, similar to stress exposure.  
Swiergiel and Dunn (2007) injected animals with varying doses of LPS and found a dose-
dependent relationship, where higher levels of IL-1β were associated with a reduction of entries 
into the open arms of the elevated plus maze and a reduction of entries into the center of the grid 
in an open field test, suggesting an increased level of anxiety.  However, they also found an 
overall reduction in mobility, making it likely that they were not only measuring anxiety, but 
also sickness behavior.  Koo and Duman (2009) also found an increase in anxiety-type behavior 
in rats injected with IL-1β, with fewer open arm entries into the elevated plus maze, but in the 
presence of reduced mobility.  In order to better study the effects of IL-1β without the 
confounding sickness behavior, Koo and Duman also tested male IL-1R1 KO mice, which had a 
reduced anxiety-type behavioral response.  These KO animals showed increased open-arm 
entries into the elevated plus maze, as well as an increased latency to enter the dark region in a 
light-dark chamber.  Similarly, Murray et al. (2013) found a reduced-anxiety type response for 
both male and female adult IL1-R1 KO mice in the elevated plus maze, with increased time 
spent in the open arms, but no effect for the total number of open-arm entries. 
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Animals exposed to different acute and repeatable physical and environmental stressors 
are found to have increased corticosterone levels, which correlate with increased concentrations 
of IL-1β in the hippocampus (Murray & Lynch, 1998).  However, the reaction to specific 
stressors varies, with evidence that some stressors, such as shock and immobilization, produced 
activation of IL-1β activity in limbic regions, while other stressors, such as predator exposure 
and FST, do not (Plata-Salamán et al., 2000).  In addition, the expression of IL-1β in the 
hippocampus and amygdala associated with stress conditions is age-dependent.  Badowska-
Szalewska et al. (2009) found levels of IL-1β increased in the amygdala and hippocampus for 
juvenile animals exposed to stress (both open field and FST paradigms), for both acute and 
chronic exposures, while aged animals only showed an effect for chronic conditions, possibly 
reflecting a learned compensatory behavioral response that prevents the neuroimmune response 
to acute conditions in aged populations, or an overall drop in the immune response in aging.  
Similarly, sex-differences have been observed.  For example, Yee and Prendergast (2010) 
injected male and female rats with LPS and found typical sickness behaviors (decreased feeding 
and locomotor activity) for both sexes, but the response to particular stressors differed by sex. 
Males were found to have exacerbated symptoms with social deprivation (housed singly), while 
group housing exacerbated females’ symptoms.  Thus, the nature of stressors can differ by sex. 
Interleukin-1 and Depression 
The overlap between sickness behavior and depressive symptoms indicates a potential 
role for IL-1 in the regulation of depressive disorders.  Adult depressive disorders are classified 
into sets of different syndromes in the DSM-V (American Psychiatric Association, 2013), each 
with a unique set of diagnostic criteria.  Included among the depressive conditions are Major 
Depressive Disorder (MDD) and Persistent Depressive Disorder (PDD).  MDD requires the 
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presence of major depressive episode for at least two weeks, in which an individual experiences 
depressed mood or anhedonia, as well as additional somatic symptoms (changes in eating or 
sleep, psychomotor agitation, or fatigue), and/or emotional or cognitive symptoms (feelings of 
guilt or worthlessness, difficulty concentrating, or thoughts of death).  PDD represents a more 
chronic condition, in which an individual experiences major or mild depressive symptoms over 
the course of at least two years.  The distinction between MDD and PDD primarily relates to the 
duration of depressive symptoms, and individuals with a PDD may experience major depressive 
episodes. 
Both MDD and PDD can develop during adolescence or adulthood, but more severe 
symptoms and higher rates of prevalence are associated with younger ages, with a mean age of 
onset for initial major depressive episode in the mid- to late-twenties.  A peak of depression risk 
starts in adolescence rises into the mid-twenties, and declines thereafter (Andrade et al., 2003).  
The prevalence of depression in later years of life is unclear.  In some ways, the aged are seen as 
vulnerable individuals, with increased risks for reactive depression, such as loss of autonomy and 
major health concerns (Schulz, Heckhausen, & O’Brien, 1994), but the elderly are also seen as 
more resilient and better prepared to face stressors and less likely to develop reactive depression 
(Baltes & Baltes, 1990).  This dichotomy of theories is reflected in research findings that have 
found both higher (i.e., Kanowski, 1994) and lower (Henderson et al., 1998) rates of depression 
among aged populations when compared to rates in the overall or younger populations. 
The mixed findings in research in aging may reflect research limitations associated with 
the aging population, with clear cohort effects and issues of selective survival of people who are 
not prone to depressive conditions (see Rothermund & Brandtstädter, 2003, for a review).  More 
recently, research that has attempted to statistically account for these and other confounds has 
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pointed to a pattern of increased risk for depression, but only among the oldest aged populations 
(Teachman, 2006).  This suggests a curvilinear function of prevalence over the lifespan, with a 
decline in middle adulthood years, and then a second peak in the older aged, especially over 80.  
In addition, when researchers have changed the focus of their criteria for depressive conditions to 
include not just individuals classified with clinical disorders (i.e., switching a focus from 
categorical criteria of depressive syndromes to continual dimensional traits of depressive 
symptoms), the increase in depressive-type conditions among the aged is strongly evident, with 
increases starting as early as the mid-50s and having a sharp incline in the late 80s (see meta-
analytic review of studies by Snowdon, 2001).  This, in part, may be explained by differences in 
reporting among different age groups, in which individuals over the age of 65 are less likely to 
report sadness than younger individuals (Gallo, Anthony, & Muthén, 1994), which has been 
replicated over several years, implying the difference is age-related and not a cohort effect 
(Gallo, Rabins, & Anthony, 1999).  Thus, as people reach an older age, there appears to be a 
general increase in the risk for the development of depressive conditions, although the nature of 
later life depression may differ from earlier developed forms of the condition.  These differences 
may also reflect changes in the neuroimmunological status of the aged population (to be 
discussed below), with specific contributions of changes in IL-1 activity. 
Research in the field of depression has recently highlighted the suggestion of a unique 
depressive condition found in the aged, with a pattern of symptoms that reflect underlying age-
related changes in the central nervous system and age-typical changes in lifestyle and life 
stressors.  Generally, when compared to younger adults, older depressed individuals will exhibit 
greater anhedonia than sadness, and prominent somatic complaints, including sleep and eating 
disturbances, fatigue, and psychomotor agitation (Holland, Schutte, Brennan, & Moos, 2010).  
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Despite a decrease in reporting feelings of sadness, older-aged depressed populations have also 
been found to have more thoughts of death and suicide (Conwell, 2009).  The Center for Disease 
Control and Prevention statistics reveal that white males over the age 85 had the highest suicide 
rate among all U.S. populations between 2002 and 2006 (Centers for Disease Control, 2009). 
The pattern of symptoms found in late life depression fit a subtype identified by 
Abramson, Metalsky, and Alloy (1989; later validated by Joiner et al., 2001) as a hopelessness 
subtype of depression that presents with suicidal ideation, psychomotor agitation, fatigue, and 
negative cognitive evaluations of the self and the world.  Because of the high prevalence of 
somatic complaints in late-life depression, including fatigue, sleep, and psychomotor 
disturbances, Holland et al. (2010) propose later in life depression is caused by disruptions to the 
central nervous system that result in overlapping disruptions to biological systems, affecting 
appetite, sleep, and sex-drive, leading to in an overall feeling of a decline in well-being. 
In essence, later-life depression carries many of the symptoms associated with the 
sickness response reviewed previously.  Alexopoulos and Kelly (2009) attribute these central 
nervous changes to changes in the cerebrovascular system, supported by the findings of Bunce, 
Handley, and Gaines (2008) who found vascular changes and hypofrontality in older adults who 
experienced depression.  Additional research has found neuroanatomical correlates (Kumar, Jin, 
Bilker, Udupa, & Gottlieb, 1998) and neurochemical changes (see Gareri, de Fazio, & de Sarro, 
2002, for a review) associated with late life depression.  In addition, there is clear evidence of an 
enhanced immune response in the aged that predisposes this population to both depression and 
vascular disease (Mast et al., 2008). 
With the perspective that late life depression may be a different type of depressive 
condition from early-adulthood and adolescent onset conditions, one must also consider the large 
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degree of variability among the elderly and different depressive conditions.  Weber et al. (2009) 
has shown among the elderly with an earlier onset condition (i.e. developed depressive condition 
in their early or middle adulthood years that persevered into late adulthood) are distinct from 
individuals who had their initial onset of depression after the age of 60.  Specifically, they found 
that individuals with earlier onset conditions had spared brain volume, showed no significant 
vascular changes, and also had preserved cognitive functions, unlike individuals with later onset 
conditions.  Weber also reports individuals who experience an earlier onset depressive condition 
are more likely to have depressive conditions that reflect a personality vulnerability, with higher 
levels of neuroticism and decreased extraversion that put them at greater risk of responding to 
typical late in life psychosocial stressors. 
In addition to the distinction between depressed elderly patients with early versus later 
onsets of the condition, there is a growing effort to look at specific forms of depression 
associated with aging, including vascular depression and age-related neurocognitive disorders.  
Depression is a known correlate of cardiac disease, especially in older adult populations, leading 
to the conceptualization of a medically related depression condition referred to as vascular 
depression, which has a strong relationship to sickness behavior (Korczyn & Halperin, 2009).  
Various studies have looked at this relationship in both prospective (depression symptoms 
anticipating cerebrovascular or cardiac conditions, e.g., Vinkers, Stek, Gussekloo, van der Mast, 
& Westendorp, 2004) and reactive (depression following cerebrovascular or cardiac conditions, 
e.g., Bour et al., 2009) research paradigms.  By looking at hospitalized cardiac patients, 
researchers have identified a profile of symptoms classified as vascular depression, with 
pronounced somatic complaints, anhedonia and psychomotor retardation, and cognitive 
impairments (Alexopoulos et al., 1997).  These patients were also found to experience less guilt 
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and have reduced insight into the severity of their condition.  However prospective studies of 
patients with this profile do not predict future cardiac conditions, with only cognitive difficulties 
being a reliable predictor of a first cardiac event within the next eight years (Naarding, 
Veereschild, Bremmer, Deeg, & Beekman, 2009). 
The anhedonia and psychomotor retardation symptoms of vascular depression probably 
reflect diffuse or localized white matter lesions that can be found in prefrontal regions (Murphy 
et al., 2007), as well within the nigrostriatal dopaminergic pathway or the prefrontal-subcortical 
circuits (Court & Perry, 2003).  Attention and other executive deficits have been associated with 
lesions of the thalamus, periventricular lesions, and small-vessel ischemia (Taylor, Aizenstein, & 
Alexopoulos, 2013).  There is no clear localization of vascular depression symptoms to a 
particular neurological profile, but rather a complex network of cortical and subcortical 
structures that may all contribute to a vulnerability to develop a vascular depressive condition 
(Alexopolous et al., 1997).  Thus, evidence supports a link between cardiovascular disease and 
depression, with common mechanisms, and evidence that each can precede the other, but the 
causal nature of this connection is tentative (Paz-Filho, Licinio, & Wong, 2010). 
With the failure to find focal lesion patterns for vascular depression, research has instead 
put a focus on degrees of neuropathology across diffuse brain regions.  In one study, of the 52% 
of post-stroke patients who developed depression, there was a significantly higher rate of 
depression among those individuals with the larger lesions, with no clear pattern of lesion 
localization (Nys et al., 2005).  More recent research has particularly focused on non-localized 
white matter lesions and overall volumetric losses.  In one such study, such measures were able 
to significantly predict depressive symptoms within three years, though the relationship was no 
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longer significant when functional losses associated with disability were accounted for in a 
regression model of depressive outcomes (Teodorczuk et al., 2010). 
Recently, Taylor et al. (2013) proposed a model of vascular depression in which regional 
changes in brain function are attributed to a remodeling of the vasculature due to disruption of 
local fiber tracts and changes in functional connectivity between executive and affective centers 
of the brain.  These localized and connective disruptions reflect both white matter lesions as well 
as general impairments in cerebral blood flow (cerebral hypoperfusion).  Important to later 
discussions in this review, they suggest that neuroinflammatory processes associated with aging 
play a critical role in the regulation of this system. 
Given the variability in the types of depression, causes, and sex- and age-based 
differences, it is not surprising that several different neurotransmitter systems are found to play a 
significant role, including serotonergic, dopaminergic, noradrenergic, cholinergic, GABAergic, 
and peptidergic functions (see Krishnan & Nestler, 2008, for a review).  In addition, activation of 
the HPA Axis is found in a large proportion of patients with depressive conditions (Manji, 
Drevets, & Charney, 2001), linking depression to stress and anxiety, as well as 
neuroimmunological activity, including the upregulation of IL-1β activity. 
As described above, IL-1 and other cytokines are associated with sickness behavior, 
which is characterized by symptoms that are common in depressed populations.  Medical 
patients with immune abnormalities (e.g., rheumatoid arthritis and allergies) are found to be at 
risk for the development of depression following the immunological response (Whalley, Jacobs, 
& Hyland, 2007), and patients undergoing cytokine treatment for medical conditions (e.g., 
multiple sclerosis, leukemia, and various forms of cancer) exhibit sickness behavior along with 
depression (Valentine, Meyers, Kling, Richelson, & Hauser, 1998; Goeb et al., 2006).  However, 
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evidence is mixed, with some studies of clinical populations finding no clear association between 
cytokine activity and depression, and confounding results because of psychologically life-
changing events coincident with treatments that can also explain the onset of depressive 
symptoms (see de Beaurepaire, 2002, for a review).  Individuals with clinical depressive 
conditions are found to have a systemic pro-inflammatory state, in both major (Owen, Eccleston, 
Ferrier, & Young, 2001) and mild (Maes, Bosmans, Meltzer, Scharpé, & Suy, 1993) depressive 
conditions, but again results are mixed and clearly not all depressed individuals show a pro-
inflammatory condition (Zorilla et al., 2001).  The use of anti-inflammatory pharmacological 
treatments for depression has also been inconsistent (see Miller, Maletic, & Raison, 2009, for a 
review).  However, these inconsistencies may be significant in understanding cases of treatment-
resistant MDD, as some of these cases may be attributed to a variation in the IL-1β gene.  For 
example, Baune et al. (2010) found MDD patients who had the rs114643 variant of the IL-1β 
gene were more likely to experience a period of non-remission over a six-week period of 
antidepressant treatment. 
While sickness behavior and depression have similar presentations, with behavioral 
patterns of reduced activity, decreased sexual behavior, decreased appetite, sleep disturbances, 
and reduced motivation, they are distinct conditions.  In sickness behavior there is an inciting 
illness with a febrile response which, combined with the energy conserving function, is thought 
to have an adaptive value to allow for healing and fighting off infections (Kent, Bluthé, Kelley, 
& Dantzer, 1992).  Clinical depression is not usually associated with a change in body 
temperature, though some depressed patients experience a relative increase in body temperature 
when sleeping that disappears when symptoms subside (Duncan, 1996).  In addition, although it 
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has been argued that there is an adaptive value to depressive conditions, such benefits are unclear 
and controversial (McLoughlin, 2002). 
Research on depression in animals is often limited to sickness behaviors.  However, using 
specialized protocols, researchers are able to isolate out depressive-type behaviors for general 
sickness responses (see Frazer & Morilak, 2005, and Gardier et al., 2009, for reviews).  For 
example, low-dosage injections of cytokines can produce a depressive response without inducing 
a hypothermic response or the complete array of sickness behaviors.  Animals with genetic 
mutations to alter cytokine activity are also employed, though there is always a concern with 
mutant animal models that the targeted genetic mutations can have a broad impact on normal 
development, possibly reducing the validity of the adult animal (Crnic, 1996). 
Certain behavioral tests have been shown to selectively change with the application of 
efficacious anti-depressant treatments, implying they are testing a depressive-type condition that 
is distinct from other sickness- or anxiety-type behaviors (Kalueff & Tuohimaa, 2004).  These 
methods include the FST the tail-suspension test, and the inescapable shock test, based on 
learned helplessness models of depression.  In addition, the sucrose preference test, a model of 
anhedonia, has also been shown to have predictive validity.  In the FST animals are placed in a 
pool of water for an extended period of time with no opportunity to escape and then are 
reintroduced to the pool at a later time.  Animals with a depressive-type response exhibit 
immobility in the second trial, failing to engage in escape behaviors.  A similar effect is 
measured in the tail-suspension test in which an animal is suspended by the tail for an extended 
period of time and the latency to discontinue escape behaviors is measured, again reflecting a 
learned helplessness response.  In the inescapable shock procedure, animals are given repeated 
shocks (i.e., to the foot or tail), and then tested for conditioned fear responses and escape 
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behavior following an escape training paradigm.  The sucrose preference test relies on the 
phenomenon that animals typically prefer a sucrose solution to water.  However, when animals 
are exposed to a chronic stressor, they fail to show a taste preference, modeling an anhedonic 
loss of sensitivity to rewards.  While all three methods test depressive-type behavior, it is likely 
there is a difference between the learned helplessness-type effects, which are based on a loss of 
avoidance behavior and the anhedonia-type effects, based on a loss of approach behavior (see 
Jacobson, 2007, for a review). 
There is mixed evidence for a learned helplessness type depressive response associated 
with IL-1β activity.  Rats exposed to an acute tail-shock stressor will develop a strong fear 
conditioning response and have poor escape learning following the stressful event, but this effect 
was reversed in animals administered IL-1ra, showing the importance of IL-1 for a typical 
depressive-type response (Maier & Watkins, 1995).  On the other hand, Koo and Duman (2009) 
found that IL-1R1 KO mice were similar to controls in the FST, showing no difference in 
learned helplessness type behavior with the constitutive prevention of IL-1R1 activity. 
As mentioned above, there is an underlying difference between learned helplessness and 
anhedonia models of depression, and though the evidence is mixed regarding the role of IL-1 for 
learned helplessness type depression, there is very clear evidence for a link between IL-1 activity 
and anhedonic depressive symptoms.  Mice exposed to chronic mild stressors have a decreased 
sucrose taste preference that correlates with changes in IL-1 activity in the hippocampus (Grippo, 
Francis, Beltz, Felder, & Johnson, 2005), such that higher levels of IL-1 production are found in 
animals with the greatest decline in sucrose preference.  Goshen and Yirmiya (2009) found 
similar changes in sucrose taste preference following CUS exposure, as well as in mice given a 
chronic administration of IL-1 without a stress exposure, indicating IL-1 is a major component of 
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the anhedonia effects of chronic stress.  As further support, Goshen et al. (2008) found that IL-
1R1 KO  mice as well as transgenic mice bred to overexpress IL-1Ra fail to show an anhedonic 
response to CUS.   Koo and Duman (2008) found both IL-1β injections and chronic stress 
exposure can induce an anhedonic sucrose taste preference in rats, which was reversed with the 
injection of an IL1-R1 antagonist.  In addition, in a follow-up study, Koo and Duman (2009) 
found a similar suppression of an anhedonic sucrose preference in IL1-R1 KO mice. On the other 
hand, Murray et al. (2013) found no genotype effect for either female or male IL1-R1 KO 
animals in a tail-shock CFC testing paradigm.  Murray cites several reasons their results may 
differ from those of other researchers, including the possibility in the differences in the 
background strains of the IL1-R1 KO mice used in the Goshen study and the background for the 
animals tested by the Koo and Murray laboratories, as well as differences in the background 
strain of WT animal strains, in which the Goshen and Murray laboratories used the same 
C57BL/6J controls while the Koo laboratory used a C57BL/6 control mouse that was bred from 
a C57BL/6N line. It should also be noted Murray used animals from an in-house inbred colony, 
while the other laboratories purchased their animals directly from Jackson Laboratories.   
Just as sex and age are associated with variations in the expression of depression in 
human clinical populations, similar effects are found in animal models of depression.  Most 
animal research on depression, and even on anxiety and sickness behavior, is conducted with 
male-only populations.  When female animals are included, some notable differences are found 
for the role of cytokines in depressive-type behavior.  Female rats are found to have reduced 
sickness behaviors and reduced depressive-type learned helplessness behavior in the FST when 
compared to males following LPS injections (Pitychoutis, Nakamura, Tsonis, & Papadopoulou-
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Daifoti, 2009).  These differences coincided with an enhanced serotonergic response in female 
animals, especially in the hippocampus and amygdala. 
Age differences in depressive-type behavior are also seen for animals exposed to stress or 
LPS injections.  Rats introduced to either a mild (open field test) or moderate (FST) stressful 
event have increased IL-1β activity, with a larger increase for aged (1-year-old) than juvenile (1-
month-old) animals (Badowska-Szalewska et al., 2009).  In addition, aged mice injected with 
LPS are found to have an exacerbated depressive-type response in both the tail-suspension and 
FST tests, characterized by both an increased level of depressive response and an increased 
duration of the response (Godbout et al., 2008).  These findings are important in interpreting the 
research discussed above showing an enhanced neuroinflammatory condition in aged 
populations, along with the increased risk for depressive symptoms found in these populations. 
Interleukin-1 and Cognitive Behavior 
With IL-1 having such a widespread impact on neural functions and potential 
involvement in neuro-degenerative diseases, it is not surprising that substantial evidence 
implicates IL-1 in normal cognitive functioning, especially for learning and memory.  Human 
data about the role of IL-1 in cognitive performance has been mixed, with evidence of associated 
impairments, or of a failure to find impairments in memory and other cognitive functions with 
increased IL-1 activity (Brydon, Harrison, Walker, Steptoe, & Critchley, 2008; Cohen et al., 
2003; Krabbe et al., 2005).  In natural illness models, individuals with cold, flu, or other mild 
bacterial or viral infections have been found to have increased circulating IL-1β levels, but 
associated cognitive impairments have not been consistently found, possibly due to a lack of 
adequate experimental controls (Vollmer-Conna et al., 2004). 
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In an attempt to better assess these effects, researchers have looked at the cognitive 
functions of individuals exposed to a peripheral infection through injection of LPS or other 
agents that are known to induce the cytokine immune response, including increasing circulating 
levels of IL-1β.  In one such study, Grigoleit et al. (2010) were able to produce a low-grade 
inflammatory response, with an associated mild fever, but they failed to find cognitive 
impairments on a wide range of declarative and non-declarative memory tests (assessed with the 
Wechsler Memory Scale – Revised) or a measure of complex executive functions (Stroop Color-
Word Test).  Others have also failed to find impairments in attention or executive function, but 
did find decreased verbal and non-verbal memory performance (Cohen et al., 2003). 
Making the picture even more complex, others found decreases in declarative memory 
performance but improvements in working memory performance (Reichenberg et al., 2001).  In 
fact, the most consistent findings across studies are decreases in processing speed and changes in 
mood, including increased anxiety and depression, that likely affect other cognitive functions, 
producing secondary memory and executive impairments (Grigoleit et al., 2010; Reichenberg et 
al., 2001; Cohen et al., 2003).  In addition, these effects are very subtle, making them difficult to 
study, and are probably dependent on the type of task and the severity of the immune response.  
Thus, one study that induced a very low-level of IL-1β increase failed to find any changes in 
cognitive performance in the induced patients when compared to placebo control patients 
(Krabbe et al., 2005). 
In an attempt to study the effects of a more natural stress-induced neuroimmunological 
response in healthy young adults, Shapira-Lechter et al. (2008) measured circulating IL-1β levels 
and changes in mood and cognitive function among a group of healthy surgical patients, in which 
patients were found to have increased levels of anxiety and depression the morning of their 
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surgery that correlated with increases in IL-1β levels.  In addition, patients with higher levels of 
IL-1β and increased changes in mood were also found to have significantly reduced declarative 
memory performance just prior to the surgery, and these effects were exacerbated in the post-
surgical stage.  Thus, naturally occurring changes in IL-1β have been associated with changes in 
cognitive performance in neurologically healthy adults.  However, these results are within the 
context of a surgical procedure, in which a vast number of other factors, including post-
anesthesia effects, could have affected their performance. 
One consistent finding of an association between immune activity and acute cognitive 
changes is found in elderly populations.  It is hypothesized that older aged populations have a 
heightened baseline neuroinflammatory state, which makes aged populations more vulnerable to 
acute infection and neural injury (see De la Fuente, 2008, for a review).  The relationship 
between age-related changes in neuroinflammation and vulnerability to infection and 
degenerative processes is well established, but complex, and the exact role of IL-1 and other pro-
inflammatory cytokines is only beginning to be understood. 
There is evidence for both a decrease (immunosenescence) and increase (inflammaging) 
in baseline neuroimmunological functioning in aged populations, both of which are related to 
increased risk to infection and physical decline, and could potentially play a role in the age-
related changes in cognition (Ostan et al, 2008; Franceschi, 2007).  Research into 
immunosenescence has focused on declines in the adaptive immune system, including changes in 
T-cell and B-cell populations and functions that prevent the initiation of an effective immune 
response (Murasko, Weiner, & Kaye, 1987).  There are also declines in the innate immune 
system, including reduced phagocytotic functions of neutrophils and macrophages in elderly 
populations that are important for elimination of pathogens (Butcher et al., 2001).  On the other 
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hand, inflammaging has up to now only been associated with changes in the innate immune 
system, with increases in the numbers of natural killer (NK) cells that play an important role in 
apoptosis, microglia activation, and cytokine activity, though the function of NK cells is often 
defective, associated with a decreased sensitivity to cytokine activity (Mocchegiani & Malavolta, 
2004).  As discussed above, microglia are the resident immune cells of the central nervous 
system and, as such, they play an important role in the release of cytokines when activated by 
either extrinsic pathogens, or intrinsic triggers, such as stress.  During normal aging there is an 
increase in the number of primed microglia, cells that are more easily induced to producing a 
rapid immune response and secrete higher levels of cytokines (Dilger & Johnson, 2008). 
These changes in neuroimmunological response have been implicated in the age-related 
susceptibility to cognitive impairments associated with infection and degenerative conditions.  
For example, the elderly are prone to develop delirium, a condition in which a patient will 
quickly develop changes in consciousness, cognitive impairments, and behavioral changes that 
are typically transient (see Cerejeira, Firmino, Vaz-Serra, & Mukaetova-Ladinska, 2010, for a 
review).  Unlike younger populations, delirium is commonly found among the elderly with 
infections, such as urinary tract infections, and in post-surgical states.  About one third of elderly 
patients who develop delirium are found to have a premorbid mild cognitive impairment and are 
less likely to fully recover from the delirium.  In addition, a significant proportion of elderly 
patients who experience immune related delirium conditions are at risk for the subsequent 
development of a neurocognitive condition and have a higher one year mortality rate.  In 
contrast, younger populations are less likely to develop immune reaction related delirium, but 
also rarely experience long-term cognitive effects. 
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Age-related changes in neuroimmunological baseline states are also thought to play a 
critical role in neurodegenerative conditions, including dementia.  The specific role of IL-1β is 
unclear for dementia conditions, but there is evidence for a link between IL-1β activity and age-
related cognitive decline.  Alzheimer’s disease (AD) patients have increased levels of IL-1β in 
their blood and autopsy specimens (Griffin, Sheng, Roberts, & Mrak, 1995; Yasutake, Kuroda, 
Yanagawa, Okamura, & Yoneda, 2006). In addition, AD patients have increased levels of IL-1β 
levels following lipopolysaccharide (LPS) injections that trigger an immune response (De Luigi 
et al., 2002).  The level of their response is greater than that found in younger adult populations, 
in keeping with the theory of a heightened neuroimmunological response for aged populations.  
However, the behavioral effects of these IL-1β elevations are unclear, with one study showing 
that increases in multiple inflammatory mediators, including IL-1β, were not significantly 
correlated with changes in behavior or AD status (severity) among a group of clinically 
diagnosed AD patients closely tracked over the course of their disease (Teunissen et al., 2003).  
Yet, another study found individuals previously diagnosed with a Mild Cognitive Impairment 
(Minor Neurocognitive Disorder) with deficits in multiple cognitive domains as well as AD 
patients had higher levels of circulating IL-1β levels (Forlenza et al., 2009).  In addition, AD 
patients were found to have higher levels of circulating IL-1β on days they experienced increased 
confusion and disorientation. 
Genetic studies of AD patients and individuals diagnosed with related dementia 
conditions have also provided supportive evidence for the importance of IL-1β and 
neuroimmunological processes for cognitive functions.  Genetic variations for genes that encode 
IL-1α and IL-1β have been associated with risk for early onset forms of AD and the rate of 
progression of AD (see Bertram & Tanzi, 2008, for a review). 
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The effects of IL-1 on AD risk and disease progression are very complex and part of a 
newly developing field of study that is only in the early stages of recognizing and understanding 
the diversity of these genetic variations.  Trompet et al. (2008) studied the cognitive functions of 
elderly individuals with a genetic variation in the coding for IL-1β converting enzyme (ICE). 
Patients with this variant express less IL-1β.  The researchers found individuals in this 
population outperformed their age-matched controls in tests of executive functions, but did not 
differ significantly on memory tests.  Another study of elderly Chinese males with a different 
polymorphic genetic variation that also decreased IL-1β levels found similar preserved executive 
functions, as well as improved working memory performance (Tsai et al., 2010).  However, 
individuals with a different genetic polymorphism for IL-1β were found to have no significant 
difference in circulating IL-1 levels when compared to non-carriers, while they were found to 
have worse working memory performance (Baune et al., 2008).  This finding could reflect the 
difficulty in monitoring real-time changes in circulating IL-1 levels, but also suggests alternate 
pathways for IL-1 influence on cognitive functions. 
Genetic polymorphisms associated with specific IL-1 functions are newly identified and 
may be very limited in scope, especially when compared with more well-established gene 
linkages, like those described for polymorphisms in the APOE gene.  Older aged individuals who 
carry at least one copy of the APOE epsilon-4 allele are at a greater risk of developing AD and, 
interestingly, they have also been found to have higher baseline levels of IL-1β (Olgiati et al., 
2010).  In addition, these same individuals are found to show the heightened 
neuroimmunological response discussed above. 
Taken together, genetic studies support the theory that neuroimmunological agents, 
including IL-1β, play a critical role in cognitive functions, especially in aged populations with a 
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heightened risk of inflammatory response and related cognitive impairments and 
neurodegenerative conditions.  While IL-1β may play a significant role in age-related cognitive 
decline, its exact function is unclear, and it likely is one of several neurological agents that 
contribute to the increased vulnerability found in aged populations.  For example, sex-differences 
point to a possible role of estrogen in modulating the effects of neuroinflammation on cognitive 
functions, with evidence of estrogen-mediated enhancement in cell proliferation during learning 
and memory and increased cell survival during stress within the hippocampus (Falconer & 
Galea, 2003).  These sex-related differences in hippocampal functions may even help explain the 
finding that women experience changes in cognitive function with the depletion of estrogen 
during menopause (Greendale et al., 2010) and post-menopausal female AD patients show a 
more significant deterioration of cognitive abilities than men (Norbury et al., 2003). 
While research in human populations has indicated a relationship between IL-1 and 
cognitive functions, the biggest advances in this field of research have come from animal studies.  
In these experiments the relationships between neuroimmunological changes and behavior have 
especially been studied for learning and memory.  The mapping of behavioral changes in 
learning and memory performance to neuroanatomical regions in animal research has typically 
split processes along a spatial vs. non-spatial dimension, with spatial learning and memory 
processes showing a strong dependence on hippocampal regions and non-spatial processes 
associated with non-hippocampal regions, including the cerebellum, basal ganglia, and frontal 
cortex (e.g., Yirmiya, Winocur, & Goshen, 2002; Avital et al., 2003). 
Testing the differences across spatial and non-spatial tasks with various manipulations of 
IL-1β activity in mice and rats has generally found that IL-1β plays an important role in spatial 
memory performance, with a less clear importance for non-spatial performance.  The Morris 
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water maze (MWM) is a classic tool used to study hippocampal-dependent spatial learning and 
memory retention in rodents (see Sharma, Rakoczy, & Brown-Borg, 2010, for a review).  In the 
standard version of the test the animal is placed in a circular pool of opaque water in which a 
small platform is hidden just below the water surface.  Highly salient spatial cues are placed 
around the testing environment to allow the animal to develop a mental spatial map of the room 
and the relative position of the platform within the pool.  Animals are first trained to find the 
platform in an acquisition phase that typically lasts three to five days, in which the animal is 
placed into the water at varying locations while the platform location is stationary across trials, 
with multiple trials on a series of consecutive days.  Learning performance is measured as a 
function changes in the latency to find the platform and distance traveled to find the platform 
over the duration of the acquisition phase.  Additional measures, such as swim speed, allow for 
the measurement of locomotor abilities that can be covaried out in analyses to better ascertain 
true learning performance.  After animals reach a pre-determined performance level that 
indicates learning has occurred, they are typically tested with a memory retention probe trial.  In 
the probe trial, the platform is removed from the pool and memory retention is measured by the 
proportion of time the animals spend in the quadrant where the platform was previously found 
(goal quadrant).  Animals with intact hippocampi will spend more time in the goal quadrant, 
indicating a memory for the platform location.  This type of learning, in which the platform 
location remains constant across trials, is spatial because the animal uses constant spatial cues to 
find the platform.  If these cues are removed, the animal fails to learn the location of the 
platform. 
Animals without normal IL-1 activity have been consistently found to have poor learning 
and/or memory for the platform location in standard MWM tests.  In a pivotal study of the 
  
32 
32 
relationship between hippocampal-dependent memory and IL-1, Avital et al. (2003) tested male 
IL1-R1 KO mice in the MWM, and found these animals had impaired learning during the 
acquisition phase, with impaired latency to find the platform.  The animals were generally slower 
than wild-type animals, but this could not account for the learning effects.  In addition, Avital et 
al. found these animals had impaired memory retention, with fewer crossings in the goal 
quadrant.  Electrophysiological measures, discussed more fully later in this paper, showed that 
animals lacking normal IL-1β activity had impaired hippocampal functioning that appeared to 
lead to poor spatial learning and memory performance.  It should also be noted Murray et al. 
(2013) found no impairments in MWM learning and retention performance, but only tested 
female IL1-R1 KO animals.  In addition, both Murray and Avital used an abbreviated 
acquisition-testing format of three trials per day over three consecutive days, potentially 
impacting the ability to find subtler, gradual differences in learning. 
Increased levels of IL-1 have also been implicated in impaired spatial learning and 
memory.  Oitzl, van Oers, Schöbitz, & Ron de Kloet (1993) found that the administration of 
intracerebroventricular injections of IL-1 had impaired performance in the early acquisition trials 
of the MWM, though these effects were time-limited.   Specifically, the effects were only 
significant when the injections were given one hour prior to the trial, with no significant effect 
when administered immediately prior to water maze exposure.  In addition, the animals were 
found to have normal acquisition by the end of the acquisition training phase, indicating the 
effect on spatial memory learning only modulates, but does not prevent, spatial learning.  
Unfortunately, the researchers did not include a probe trial to test memory retention.  More 
recently, Moore et al. (2009) also found that excessive levels of IL-1β can modulate MWM 
acquisition, as well as memory retention.  Mutant mice bred to overexpress IL-1β when injected 
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with the FIV-Cre virus were found to have impaired learning on the second day of acquisition 
(though a non-significant trend), with normal learning performance by the last day of acquisition 
training, but with impaired memory retention in the probe trial.  Thus, IL-1, and more 
specifically IL-1β, contributes strongly to long-term spatial memory performance.  However, the 
effect on memory retention could be secondary to impaired or altered learning processes, as 
evidenced by the findings of modulated learning performance. 
In an attempt to more closely study the effect of increased levels of IL-1β on the 
acquisition, consolidation, and retention of spatial learning, Thomson and Sutherland (2006) 
gave rats injections of IL-1β at different stages of the MWM, as well as in a delayed-matching-to 
place (DMP) version of that MWM that tests working memory.  In their version of the DMP 
procedure, the location of the platform was changed every day or after two days, assessing the 
ability for animals to generate a spatial map that is flexible and allows for consolidation of new 
information to old information.  They also varied the timing of IL-1β injections, including 
injections prior to and immediately following acquisition trials.  Thompson and Sutherland found 
no impairments in MWM performance for both the working memory and standard acquisition 
formats of the MWM, as well as no impairment in memory retention.  They contend that IL-1β 
levels were clinically significant, as the animals were found to have significant weight loss, 
consistent with an overall sickness response. However, no other tests of sickness behavior were 
given and animals were not found to have overall decreased swim speed, which is typically 
found in the MWM when other measures of sickness behavior are significant.  In addition, the 
retention test was administered after animals had been through both the DMP and standard 
MWM acquisition trials, making it likely that animals had overlearned the location of the task by 
the time the probe trial was given. In support of their findings, Murray et al. (2013) found no 
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differences in a non-spatial beacon water maze learning and memory task using female IL1-R1 
KO and WT animals.   
Chen et al. (2008) also tested working memory performance in mice with increased IL-1β 
activity, using a version of the DMP in which the pool was adapted to accommodate a five-arm 
radial maze.  A hidden platform was placed at the end of different maze arms across days, thus 
maintaining the requirement of acquiring a spatial cognitive map to locate the platform, but less 
reliant on the need for a detailed spatial map.  LPS injections were administered on the last day 
of testing and performance was compared to learning on the prior day.  Animals were found to 
have decreased working memory performance following LPS injections, which was significantly 
more pronounced for aged than young animals. In addition, the older animals were found to have 
a stronger inflammatory response in the hippocampus, with a greater number of activated 
microglia and higher levels of localized IL-1β, consistent with earlier discussed findings of a 
heightened immune response in aging that was linked to hippocampal function and memory 
performance. 
While the MWM is a good measure of hippocampal-dependent spatial memory 
performance, it is also sensitive to impairments in locomotor performance that can affect 
interpretation of learning and memory performance.  Contextual Fear Conditioning (CFC) is a 
different measure of spatial memory in animals that is also impacted by locomotor functions, but 
to a lesser degree than the MWM.  In the standard CFC test, animals are introduced to a novel 
cage and given a mild foot shock.  Fear conditioning is measured by presence of a fear response 
(freezing) when reintroduced to the same apparatus one to two days later.  The test is a measure 
of spatial memory, as the animal is conditioned to particular spatial cues to recognize the 
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previously novel apparatus, but is not nearly as reliant on the ability to form a spatial map as the 
MWM. 
IL-1 is known to affect locomotion as part of a complex sickness behavior response 
(reviewed above), which can make interpretations of MWM more difficult.  Thus, the CFC 
paradigm, which is less sensitive to locomotor impairments, can be used to support the findings 
that impaired MWM spatial memory performance; ensuring impairments in performance are due 
to impaired memory processes and not sickness-related locomotor changes.  Pugh et al. (1998) 
found that LPS injections, which induce a complex sickness behavior response along with the 
up-regulation of IL-1β, produced impairment in CFC that was reversed with the administration 
of IL1-R1a, implying the cognitive effects of the sickness response were dependent on IL-1β 
activity.  However, Thompson and Sutherland (2005) found IL-1β injections were not sufficient 
to elicit impairments in CFC on their own.  While the researchers did not measure other sickness 
behaviors, they used dosage levels that typically produce sickness behavior, implying the 
sickness response and related memory impairment found with LPS injections may differ from 
the sickness response induced by isolated IL-1β injections.  On the other hand, studies with IL1-
R1 KO mice have shown impaired spatial memory performance in the CFC paradigm (Avital et 
al., 2003), suggesting the loss of normal IL-1β activity can affect contextual learning that is 
reliant on the use of spatial information.   However, Murray et al. (2013) found no difference 
between IL1-R1 KO and WT animals in a tail-shock version of the CFC.  Murray suggests their 
contradictory findings likely reflect a difference in testing paradigms, but it should also be noted 
they also conducted separate experiments and separate data analyses for the male and female 
animals, which were then compared to Avital’s original study with only male animals.   
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Generally, findings show spatial learning and memory performance is affected by 
abnormalities in IL-1β activity, with impairments associated with both abnormally low and high 
levels of IL-1β.  However, the effects are inconsistent, with some studies showing effects on 
acquisition and others showing effects only for retention, and performance varying across 
different testing paradigms.  The variability of the research has revealed an important aspect of 
IL-1β effects on cognitive functions, with clear evidence of dose-dependent effects.  Gibertini 
(1998) trained animals in a standard MWM acquisition test, as well as a working memory 
version, with injections of IL-1β administered prior to learning.  Low dose injections did not 
affect standard MWM learning and retention, while high dose injections actually facilitated 
performance.  On the other hand, low dose injections led to poor working memory performance.  
However, when another group of researchers compared rats injected with either IL-1β or IL-1ra 
(IL1-R1 antagonist) following the acquisition phase of the standard spatial version of the MWM, 
spatial memory retention performance was impaired in a probe trial for the group with decreased 
IL-1β activity and intact for animals injected with IL-1β (Yirmiya et al., 2002).  While these 
findings were inconsistent with the previous findings from Gibertini, the authors carefully 
compared the dosage levels across the different studies and determined there was a U-shaped 
dose-dependent effect of IL-1β on spatial memory performance, with an optimal moderate level 
required for normal hippocampal mediated memory functions.  They also proposed that absolute 
levels of such dose-dependent effects likely vary across different types of behavioral tests, and 
account for many of the contradictory findings in the literature. 
On the other hand, testing of non-spatial memory performance more clearly shows a lack 
of effect of IL-1β activity, even across different testing paradigms.  There are several variations 
of the MWM that reduce an animal’s reliance on spatial memory to find a platform.  Typically, 
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these non-spatial variants of the MWM require animals to swim to a platform that is either 
visible above the water line or is marked by a salient visual cue, such as a post or flag attached to 
the platform.  Avital et al. (2003) found no difference in the acquisition or retention performance 
of young adult male IL-1R1 KO mice and wild type animals, suggesting that a lack of IL-1β 
activity has no significant impairment on non-spatial memory performance.  Similarly, findings 
have failed to reveal impairments in non-spatial memory performance induced by increases in 
IL-1β activity.  In a study of transgenic male and female young adult mice bred to overexpress 
IL-1β when injected with FIV-Cre virus, acquisition rates were equivalent for IL-1β 
overexpressing animals and control animals (Moore et al., 2009).  These findings extended to 
non-water maze paradigms, including a non-spatial fear-conditioning task.  The procedure is 
similar to the CFC task, except that conditioning is no longer based on association to a particular 
environmental spatial context, but to an auditory cue in a novel apparatus. 
While research has clearly established both IL-1’s importance in normal spatial memory 
functions and its lack of significant role in non-spatial memory performance, other tests that are 
not heavily spatial in format have established that IL-1 plays an important role in more general 
learning and memory processes.  Transgenic mice deficient in the P2X7 receptor, which mediates 
the induction of IL-1β expression in the hippocampus, were found to have impaired learning in a 
Y-maze task (Labrousse et al., 2009), with decreased exploration of a previously blocked maze 
arm.  While this task is still a spatially driven learning test, it is less reliant on having a detailed 
spatial map, such as required in the MWM where the animals must use cues to find a very 
specific location in a large spatial field.  Rather, the delayed Y-maze test requires just the ability 
to use enough spatial cues to recognize the different arms.  However, impairments in 
performance may also reflect a decreased interest in exploring the novel arm, which has been 
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found to be affected by IL-1β levels in mice (Spadaro & Dunn, 1990).  P2X7 receptor null mouse 
have, however, been found to have a normal novelty-suppressed food response (Basso et al., 
2009). 
IL-1β has also been found to play a role in simple motor learning in young male rats.  
Larson, Hartle, and Ivanco (2007) found animals injected intraperitoneally with moderately high 
doses of IL-1β were impaired in the learning of a motor task in which they were required to learn 
a field of obstacles along a narrow elevated platform to reach a food reward.  The effects were 
not due to a reduced motivation for the reward, as animals were comparable to controls in the 
speed to reach the goal on an un-obscured elevated platform. 
The Hippocampus and Interleukin-1 
As outlined above, IL-1 contributes to the immune response to pathogens, and also 
contributes to the regulation of the HPA axis in response to threat.  This effect has a well-
established impact on sickness behavior, as well mood and cognition, and can be linked to the 
role of IL-1 in the regulation of structural and functional properties of the hippocampus.  The 
hippocampus maintains diffuse connections with limbic and cortical structures, with more dorsal 
regions associated with learning and memory functions and ventral regions associated with the 
regulation of affect (see Small, Schobel, Buxton, Witter, & Barnes, 2011, for a review).  Two 
important aspects of the hippocampus, long-term potentiation (LTP) processes and neurogenesis, 
have been linked to IL-1 and its impact on cognition and emotion. 
Learning and memory are dependent on synaptic plasticity within the hippocampus, with 
repeated activity at a synapse producing an enduring potentiation, reflecting a so-called 
strengthening of the connection between the two cells (LTP).  This synaptic plasticity is critical 
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for memory consolidation, as there is often impaired learning and memory performance in 
animals with blocked LTP processes (see Lynch, 2004, for a review). 
As discussed above, learning and memory performance in rodents is affected by IL-1 
activity, with the complete loss of IL-1 activity (Avital et al., 2003) as well as very high levels of 
IL-1 (Oitzl et al., 1993) producing impairment in MWM acquisition and recall performance.  
This effect may be partly explained by a disruption in hippocampal LTP processes with changing 
levels of IL-1.  Oitzl et al. (1993) found that the timing of IL-1 injections that was able to disrupt 
learning was consistent with the time frame needed for suppression of LTP.  Specifically, 
injections 10 minutes prior to learning had no effect on performance, while injection 60 minutes 
prior to learning had a significant impact.  These findings were consistent with prior research that 
has found a 25-minute window for the disruption of the mossy fiber CA3 pathway in mice 
hippocampal neurons incubated with IL-1β and rat CA1 pyramidal cells that were found to have 
enhanced synaptic inhibition one hour after IL-1β perfusion. 
The impact of IL-1 on synaptic plasticity is not limited to LTP processes, as it has also 
been found to affect short-term plasticity.  Avital et al. (2003) found that IL-1R1 KO mice were 
selectively impaired in spatial but not non-spatial learning and memory tests and also had deficits 
in short-term plasticity, with enhanced paired pulse inhibition and decreased paired-pulse 
facilitation in cells of the dentate gyrus of the hippocampus.  The cells of area CA1 of the 
hippocampus in these animals also showed a lack of LTP function. 
The exact process by which IL-1 impairs LTP activity in the hippocampus is not yet fully 
understood and is beyond the scope of the current paper.  Generally, IL-1 is found to be 
necessary for LTP, but at high doses inhibits LTP and acts by regulating glutamate release, 
NMDA receptor function, and Ca2+ channel activity (Ross et al., 2003). 
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Given that IL-1 has a negative impact on synaptic plastic and LTP, there has been a great 
deal of interest in determining the relationship between neuroinflammation and impaired 
memory and emotion processes associated with the hippocampus.  Microglia may play an 
important role in this relationship, as microglia upregulate the production of IL-1β.  Transgenic 
mice bred to overexpress IL-1β are found to have higher levels of activated microglia in the 
hippocampus (Moore et al., 2009), and the increased activation of microglia in these animals had 
a negative impact on MWM performance, with microglia activation levels that correlated with 
performance impairment.  In addition, mutant mice with the Swiss APP gene (Tg-SwDI) are 
found to have high levels of activated microglia along with increased numbers of beta amyloid 
deposits associated with Alzheimer’s disease and related impaired learning and memory 
performance (Fan et al., 2007).  Animals administered a long-term treatment of minocycline, 
killing off the activated microglia, were found to have normal spatial memory performance on 
the Barnes Maze, where they learn an escape route from an apparatus based on spatial cues.  
Importantly, these changes in performance were only related to the loss of microglia activation, 
but in the absence of changes in the amount of beta-amyloid deposits developed. 
Synaptic plasticity, such as LTP, in the hippocampus is accompanied by another 
important neural plasticity, neurogenesis.  The hippocampus is one of two structures know to 
undergo continuing neurogenesis throughout the lifetime, the other being the olfactory bulb.  It 
has been demonstrated that LTP promotes the survival and proliferation of new neurons (Bruel-
Jungerman, Davis, Rampon, & Laroche, 2006).  In return, neurogenesis is thought to facilitate 
synaptic plasticity in the hippocampus, as evidenced by findings that animals treated with the 
DNA-methylating agent methylazoxymethanol acetate (MAM), which prevents neurogenesis, 
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have disrupted hippocampal-dependent conditioned learning but not non-hippocampal-dependent 
learning (Shors et al., 2001). 
Recently, hippocampal neurogenesis has become a popular topic for researchers 
interested in the pathophysiology and treatment of depression and anxiety; inspired by findings 
that hippocampal neurogenesis is required for the behavioral effects of anti-depressant 
medications (e.g., Santarelli et al., 2003).  One class of antidepressants, selective serotonin 
reuptake inhibitors (SSRIs), upregulate the expression of brain-derived neurotropic factor 
(BDNF) within the hippocampus and promote neurogenesis (Mahlberg, Eisch, Nestler, & 
Duman, 2000; Brunoni, Lopes, & Fregni, 2008).  Inflammatory activity is generally known to 
inhibit hippocampal neurogenesis (see Dowlati et al., 2010, for a review), yet evidence for the 
relationship between neurogenesis and antidepressant efficacy has been mixed.  For example, 
Eyre and Baune (2012) conducted a meta-analysis of 16 studies of depressive-type behavior in 
rodents exposed to a chronic stressor prior to the administration of an antidepressant.  Only 11 of 
the 16 studies found the antidepressant efficacy was correlated to hippocampal neurogenesis.  
However, the lack of a consistent finding may also reflect differences in the timing of exposure 
to the antidepressants.  In fact, a later study found disruption to hippocampal neurogenesis 
following the administration of an pro-inflammatory agent (LPS) was time-dependent, with 
effects limited to the early stages of synaptogenesis instead of earlier stages of cell proliferation 
and neuronal determination (Chugh, Nilsson, Afjei, Bokachi, & Ekdahl, 2013). 
It has been shown that stress-related increases in immune activity can also have a 
negative impact on hippocampal neurogenesis, and help to explain the relationship between 
chronic stress and the development of mood disorders.  IL-1 contributes to the regulation of HPA 
axis activity, especially in conditions of chronic stress, and therefore has an impact on symptoms 
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of depression and anxiety.  Koo and Duman (2008) found both acute stress exposure and 
administration of IL-1β are associated with suppressed hippocampal cell proliferation in rats.  In 
addition, these researchers found that blocking IL-1 activity (using injections of IL-1Ra in rats 
and testing IL-1R1 KO mice) reduced the antineurogenic effects of both acute and chronic stress 
events as well as decreased anhedonia in a sucrose preference test.  These findings support 
Goshen et al. (2008) who found IL-1R1 KO mice and transgenic mice bred to overexpress IL-1ra 
are also spared hippocampal antineurogenesis effects associated with CUS exposure, 
accompanied by a lack of a typical anhedonia response associated with this chronic stress event.  
Taken together, these findings show that IL-1 upregulation, whether the result of stress or an 
immune response to a pathogen, has a negative impact on hippocampal neurogenesis, in turn 
contributing to depressive conditions. 
The effects of stress and neuroinflammation on hippocampal function and related 
behaviors are modulated by both age and sex.  Aging is associated with a heightened 
neuroimmunological response in humans, as discussed above, and similar findings are found in 
animal models of aging and stress.  Rats exposed to a stressful event (an open field test or FST) 
are found to have increases in IL-1β reactive cells of the hippocampus, but this effect is much 
stronger for older (1-year-old) adult mice than younger (1-month-old) juvenile mice (Badowska-
Szalewska et al., 2009).  These differences in the neuroimmune response carry over into 
differences in LTP suppression in the presence of IL-1β injections, where aged rats (22-months-
old) were found to have a very high concentration of IL-1β concentration in the dentate gyrus of 
the hippocampus when compared to younger adult animals (4-months-old), accompanied by a 
higher degree of inhibition of LTP induction as well as LTP maintenance (Murray & Lynch, 
1998).  Older animals were also found to have a higher level of circulating corticosteroids, 
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supporting the relationship between impaired LTP function and an increased 
neuroimmunological states in aging. 
In addition to differences in LTP suppression associated with the neuroimmunological 
response, aged mice are found to have increased numbers of activated microglia and astrocytes 
in the dentate gyrus of the hippocampus, as well as higher rates of impaired neurogenesis in this 
area (Kuzumaki et al., 2010).  It has been shown the decline in hippocampal neurogenesis 
associated with aging has effects on learning and memory performance, and this relationship 
seems to graded, such that animals with the largest loss of neurogenesis have the poorest 
performance on the MWM test of spatial learning (Drapeau et al., 2003). 
The reduction in neurogenesis in aging is not uniform, with different regions showing 
higher levels of anti-neurogenesis.  The hippocampus maintains a functional topographical 
organization, with more dorsal (septal) regions having strong projections to the mammillary 
bodies and retrosplenial cortex and more ventral (temporal) regions have strong projections to 
the nucleus accumbens and reciprocal connections to the amygdala (Moser & Moser, 1998).  The 
dorsal regions of the hippocampus are associated with learning and memory functions, while the 
ventral regions are found to have a more significant role in emotion and anxiety-related behavior 
(Fanselow & Dong, 2010).  Jinno and Kosaka (2010) compared young (2-months-old) and older 
(10-months-old) adult mice for neurogenesis in these different regions.  There was an overall 
finding of greater neurogenesis in dorsal regions than ventral regions, for both young and old 
animals, but the older animals had an overall lower rate of neurogenesis, and this was especially 
reduced in the ventral regions.  Importantly, there were no changes in gliogenesis across the age 
groups.  These findings are consistent with findings in aged human populations that depression 
frequently precedes dementia in aged populations (Korczyn & Halperin, 2009). 
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In addition to age-differences in immunological responses to stress, sex modifies the 
effects of stress on hippocampal neurogenesis.  Circulating levels of ovarian hormones (estradiol, 
progesterone, and corticosterone) in the estrous cycle affect neurogenesis, and appear to have a 
protective effect on neurogenesis in times of stress.  Male animals display suppression of 
neurogenesis when exposed to a predator odor (Falconer & Galea, 2003) or acute foot shock 
(Shors et al., 2007) accompanied by increases in corticosterone, while females will still have an 
increase in corticosterone levels, but no suppression in neurogenesis.  A similar finding of 
preserved neurogenesis for females has also been found with chronic stress exposure 
(Westenbroek, Den Boer, Veenhuis, & Ter Horst, 2004).  These findings are attributed to a sex-
based difference in HPA axis functioning, where females have higher baseline levels of 
corticosterone and a reduced spiking of these levels in response to more moderate chronic stress 
events (Brummelte & Galea, 2010).  Female rodents undergo estrous and acyclicity as they age, 
leading to a reduction in cycling ovarian hormones.  The loss of ovarian hormones has been 
found to increase basal neuroinflammation due to a reduction in anti-inflammatory estrogen 
receptors in aged ovariectomized mice (Bendusi et al., 2012).  Generally, research shows chronic 
and moderate levels of circulating ovarian hormones are associated with an increase in 
hippocampal neurogenesis (see Pawluski, Brummelte, Barha, Crozier, & Galea, 2009, for a 
review).  However, most of this research is conducted with ovariectomized animals and estradiol 
injections and the findings are inconsistent across studies.  In fact, it has been well documented 
these sex-based differences even vary across species, with voles, rats, and mice having been the 
primary research subjects (see Gould & Tanapat, 1999, for a review).  Lagace, Fischer, and Eisch 
(2007) extended these findings to find a species-specific age by sex interaction effect, in which 
the administration of the anti-depressant fluoxetine preserved neurogenesis in aged female rats, 
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but not aged male rats, nor female nor aged mice.  Despite the variability in research findings, 
there is overall support for sex-based differences in neurogenesis, which can help to explain sex-
based differences in depression and memory, especially with aging in human populations.  Thus, 
with the loss of circulating ovarian hormones there is loss of neuroplasticity in the hippocampus, 
which can differentially impair females and males, especially for aged populations. 
The Current Study 
Recent investigations with human clinical populations, as well as animal models have 
demonstrated the important of IL-1 for complex emotional and cognitive functions, including 
depression, anxiety, learning and memory.  These effects, especially for depressive symptoms, 
are found to differ across the sexes, especially for aged populations, coinciding with changes in 
the neuroimmune system.  In addition, aged populations are prone to cognitive decline, which 
has also been linked to neuroinflammatory changes. 
IL1-R1 KO mice have been important in studying the role of IL-1 in young adult animals 
for emotional and cognitive functions, but there has yet to be a comprehensive study of the 
effects of age and sex with these animals (see Appendix B for a summary of prior behavioral 
studies of IL1-R1 KO animals).  The current study looks at the role of IL-1 activity on a general 
spectrum by conducting a series of behavioral and neuroanatomical measures of an IL1-R1 KO 
mouse, including both male and female animals. First, a broad-based behavioral phenotyping 
battery was conducted, measuring general activity, locomotion, facial morphometrics, emotional 
responses, and cognitive functions.  Second, to determine age-related changes in these behavioral 
tests, a subset of behaviors were tested at two different ages, in younger adult animals (2–5 
months of age) and in older adult animals (12–14 months of age).  Third, possible 
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neuroanatomical parameters were explored, including differences in gross anatomy, structural 
abnormalities, and the general morphology and distribution of microglial cell populations. 
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CHAPTER 2:  GENERAL METHODS 
Subjects 
Adult IL1-R1 KO mice and WT mice (on a C57B1/6 background strain, obtained from or 
bred from Jackson Laboratory stock) were used. A total of 24 IL1-R1 knockout mice (12 male, 
12 female) and 24 wild-type mice (12 male, 12 female) were tested, balanced for sex and tested 
in two cohorts. One animal (KO female) died after completing only the FST.  Animals were 
housed three to six per cage and provided food and water ad libitum.  The housing facility was 
maintained at 23° C with lights on from 7:00 AM to 7:00 PM.  All procedures were approved by 
and met strict compliance requirements of the Institutional Animal Care and Use Committee of 
the Queens College of the City University of New York.  Animals were approximately two to 13 
months of age during behavioral testing (see Appendix B for cohort ages for each behavioral 
test).  A subgroup of behavioral tests was administered twice to evaluate age effects, with a range 
of approximately six to 11 months between testing sessions.  Animals were approximately 14 
months of age at time of sacrifice for neuroanatomical measures. 
Rarely, individual animals were excluded from specific behavioral tests due to physical 
limitations (skin lesions and/or poor motor control).  Animals were acclimated to testing rooms 
in their home cages for 60 minutes prior to behavioral testing, and the same experimenters were 
used across days for each behavioral test.  Behavioral testing materials were cleaned and wiped 
down before and after each animal was tested, unless otherwise specified.  At least one 
experimenter was blind to animal genotype during testing, and a blinded evaluator scored all 
behavioral data.  Experimental groups were tested in random sequences across different 
behavioral tests and testing days. 
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Statistical Analyses 
Statistical analyses were conducted using the Statistical Package for the Social Sciences 
(SPSS) software version 22 (IBM Corp. Armonk, NY).  All tests were conducted with both male 
and female animals, and analyses focused on gender and sex effects, as well as genotype by sex 
interaction.  Age effects were also analyzed for a subset of tests administered at two different 
ages.  Some tests were conducted on a single cohort of animals, while other behavioral tests were 
conducted using both animal cohorts.  In tests where both cohorts were tested, cohort effects 
were evaluated.  In most instances, no significant cohort effect was observed, nor were there 
significant interactions between the cohort variable and other variables of interest and the 
reported data is based on combined cohorts.  Analyses with a significant cohort interaction 
effects were further assessed with adjustments to the data to balance out cohort differences, and 
in most instances revealed no change in the significance of other variables of interest.  Again, in 
these instances the reported data is based on combined cohorts, unless otherwise indicated.  In 
addition, in the rare case adjustments for cohort effects revealed a significant effect that had 
previously been masked by cohort interaction effect; the resulting analyses are reported for the 
adjusted data values, with the adjustments explained more fully for that particular measure. 
Extreme individual data points of two or more standard deviations from a specific 
measure mean were removed from reported data sets.  The removal of outliers is accounted for in 
the results for each individual measure. 
Figures 
Data in figures are presented as means and standard error of the means.  Asterisks (*) 
represent results that are statistically significant at p < .05. 
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CHAPTER 3:  SPECIFIC AIM 1 
Specific Aim 1 was to study the behavior and gross phenotype of IL1-R1 knock out (KO) 
mice using a broad-based behavioral and gross anatomical phenotyping battery that 
included measures of general activity and locomotion, facial morphometrics, emotional 
responses, and cognitive functions. 
IL1-R1 KO mice have reduced signaling of the IL-1 pathway, making them a convenient 
model for testing the importance of IL-1 in normal behavioral activity (Glaccum et al., 1997).  
As reviewed earlier, IL-1 plays an important role in the neuroinflammatory response and 
sickness behavior, as well as normal hippocampal functioning that impacts both cognitive and 
emotional processes (Blanco et al., 2008).  However, prior research conducted with IL1-R1 KO 
animals has been limited to primarily male animals and also limited to a subset of cognitive and 
emotional behavior (e.g., Koo & Duman, 2008).  In the one case of a study that included both 
male and female animals in four behavioral tests (elevated plus, Y-maze, CFC, and open field), 
but each sex was tested in separately with separate data analyses (Murray et al., 2013).  
Therefore, the current study seeks to expand testing to include both male and female animals 
across a broader array of behaviors, tested in the same cohorts.  Animals were tested for their 
general activity and locomotor functions, as abnormalities could indicate a sickness-type 
response (Bison et al, 2009).  Morphometric measures of facial features were also quantified, as 
IL-1 activity has been shown to be necessary for normal embryonic and neuro-developmental 
processes, including guiding cortical cell migration (Ma et al., 2014) and postnatal bone growth 
in rats (MacRae, Ahmed, Mushtaq, & Farquharson, 2007).  Emotional and cognitive functions 
were tested, including tests applied in prior research with IL1-R1 KO mice (e.g., MWM and 
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Elevated Plus Maze, both tested by Koo and Duman, 2009) and measures previously untested 
with this KO mouse strain (e.g., Social Interaction Test and the FST). 
Specific Methods 
General Activity and Locomotion 
Gait. 
Animals.  A total of 23 IL1-R1 KO mice (12 male, 11 female) and 24 WT mice (12 male, 
12 female) were tested in two cohorts. 
Procedure.  An enclosed straight runway measuring 94 x 7 x 10 cm was lined with white 
paper.  Non-toxic red paint was applied with a paintbrush to the fore paws while non-toxic blue 
paint was applied to the hind paws.  Animals were placed at the start of the runway and gently 
prodded to run the length of the runway.  Repeated trials were required for some animals until a 
series of at least three complete paw placement sequences could be visualized.  Measurements 
were obtained for stride length (distance from one placement of the paw to the next placement of 
the paw) for all four paws, stride width (distance between right and left paws) for both fore and 
hind paws, and interstep distance (measurement of the length between consecutive steps) for 
both fore and hind paws.  Three samples were obtained for each measurement, with the median 
of the three used for subsequent analyses. 
Facial Morphometrics 
Snout Morphometrics. 
Animals.  A total of 12 IL1-R1 KO mice (6 male, 6 female) and 12 WT mice (6 male, 6 
female) were tested. 
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Procedure.  Using a digital camera, animal faces were photographed against a ruler with 
their eyes open and whiskers spread.  Pictures were then viewed on a computer and 
measurements were calibrated with the ruler.  Measurements were calculated for philtrum length 
(distance from the center top edge of the mouth to the top of the base of the nose), and snout 
length (distance from the midline of the eyes down to the tip of the snout). 
Eye Morphometrics. 
Animals.  A total of 12 IL1-R1 KO mice (6 male, 6 female) and 12 WT mice (6 male, 6 
female) were tested. 
Procedure.  Using a digital camera, animal faces were photographed against a ruler with 
their eyes open and whiskers spread.  Pictures were then viewed on a computer and 
measurements were calibrated with the ruler.  Measurements were calculated for the inner 
canthal length (distance between the proximal corners of the right and left eyes), outer canthal 
length (distance between the distal corners of the right and left eyes), palpebral fissure width 
(peak distance between the lower and upper eyelid edges), and palpebral fissure length (peak 
distance between the proximal and distal corners of the eye). 
Visual Cliff. 
Animals.  A total of 23 IL1-R1 KO mice (12 male, 11 female) and 24 WT mice (12 male, 
12 female) were tested in two cohorts. 
Procedure.  Following up on early observations that some animals appeared to have 
smaller eyes, animals were tested on the visual cliff to test for visual impairment.  A clear 
Plexiglas sheet measuring 45 x 20 cm was placed on a rectangular frame that visually divided the 
field into two distinct areas.  The “cliff” area was open to give the appearance of a drop in height 
of 20 cm.  The “safe” area was darkened, giving the appearance of solid ground.  Animals were 
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placed in the middle of the safe side of the apparatus and allowed to freely explore the safe and 
cliff sides for three minutes.  Number of entries and total time spent on the cliff and safe sides 
was recorded.  Normal animals are expected to approach the cliff side with caution, while 
uninhibited exploration of the cliff side could indicate an inability to perceive the apparent cliff 
and possible visual impairment. 
Emotional Responses 
Open Field. 
Animals.  A total of 22 IL1-R1 KO mice (12 male, 10 female) and 22 WT mice (10 male, 
12 female) were tested in two cohorts.  Three additional animals (two WT males and one KO 
female) were not tested due to the presence of sores and diminished body weight suggestive of 
poor health. 
Procedure.  Animals were placed in a white, box-shaped apparatus measuring 50 x 50 
cm, divided by tape into a 3 x 3 grid.  Each grid square measured 16.67 x 16.67 cm, with eight 
“outer” squares bordering an outer wall and one open “inner” square.  Animals were placed in 
the inner square and allowed to freely explore for six minutes.  Exploration was assessed by 
counting the number of crossings made across grid lines during three continuous two-minute 
periods (“bins”), reflecting general locomotor and exploratory behavior.  Animals’ latencies to 
exit the center square and initiate grooming activities were scored.  The number of grooming and 
rearing behaviors were also counted.  These measures are thought to assess anxiety-like 
behavior, as animals have a natural tendency to avoid open areas where they are at greater risk 
for predators.  It is expected that normal animals will, over time, increase their exploration of the 
center of the apparatus, while more anxious animals will instead hug the walls of the apparatus.  
Normally, when first placed in the apparatus, animals will quickly exit the center square to seek 
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the safety of an outer wall, but an anxious animal may show a fear-related freezing response, 
resulting in increased latencies to exit the center square.  In addition, the latency and frequency 
of grooming and rearing behaviors are thought to be indicators of both of both heightened and 
reduced anxiety levels (Kalueff & Tuohimaa, 2005).  For example, increased anxiety may lead to 
compulsive-type behaviors, with a decreased latency to groom and overall increase in the 
frequency of grooming behaviors.  However, both low and high levels of stress have also been 
associated with increased grooming behavior, as measured in the total time spent grooming. 
Elevated Plus Maze. 
Animals.  A total of 23 IL1-R1 KO mice (12 male, 11 female) and 23 WT mice (11 male, 
12 female) were tested in two cohorts.  One additional animal (one WT male) was not tested due 
to the presence of sores and diminished body weight suggestive of poor health. 
Procedure.  The elevated plus maze apparatus was comprised of a central platform, 
measuring 15 x 15 cm and elevated 114 cm above the floor.  Arms were attached to each of the 
sides of the central platform (measuring 61 x 15 cm) in a “plus” shape, at the same height as the 
central platform.  Two opposite arms were painted white and had no walls (“open” arms) while 
the other two arms were painted black and enclosed with 30 cm high walls (“closed” arms).  
Animals were placed on the center platform and allowed to freely explore for five minutes.  
Latency to exit the platform was recorded.  Longer latencies to exit the center platform when 
placed on the apparatus are indicative of a strong anxiety-type response, as the animal freezes in 
place before seeking safety in one of the closed arms.  Additionally, and the proportion of time 
spent on the open arms, closed arms, and central platform were scored.  Increased time spent in 
the closed arms is thought to indicate a heightened level of anxiety, as animals will avoid 
exposure to predators in the open arms. 
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Novelty-Suppressed Feeding. 
Animals.  A total of 11 IL1-R1 KO mice (5 male, 6 female) and 11 WT mice (6 male, 5 
female) were tested.  One additional animal (one WT male) was not tested due to the presence of 
sores and diminished body weight suggestive of poor health. 
Procedure.  Animals were food-deprived for 24 hours and then placed into the open field 
apparatus described above.  After a five-minute habituation period, animals were removed and a 
mash made of the animals’ standard food pellets (PicoLab Mouse Diet 20, LabDiet, St. Louis, 
MO) and water was placed on a piece of waxed paper secured to the middle of the central grid 
square.  Each animal was immediately reintroduced to the apparatus in a corner distant from the 
food.  Latencies to first sniffing or biting of the food mash were measured, as well as total 
number of approaches (sniffs or bites) and entries into the center grid square over a five-minute 
trial.  Normally, animals will explore the introduction of a desirable novel stimulus (the food 
mash) in a familiar environment, even if the stimulus is placed in an open, exposed area.  
Increased latency to approach the food and fewer approaches to the food or entries into the center 
grid square are indicative of increased anxiety, suppressing the instinct to explore the desirable 
novel stimulus. 
Y-Maze. 
Animals.  A total of 11 IL1-R1 KO animals (6 male, 5 female) and 12 WT animals (6 
male, 6 female) were tested. 
Procedure.  The Y-maze apparatus was comprised of an enclosed starting runway 
measuring 30 x 9 x 10 cm, terminating in two identical upper arms measuring 30 x 9 x 10 cm 
each, at a 45 degree angle from the starting runway.  Animal home cages were placed between 
the two upper arms at the top of the Y-end of the maze as a motivator for animals to move 
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towards the end of the maze.  A plastic opaque rectangle was placed approximately 10 cm from 
the starting end of the runway before each trial.  The animal was placed in the starting end of the 
runway.  The plastic barrier was then removed and the animal was allowed to freely explore the 
maze until entering one of the upper arms.  After entering an arm the animal was removed from 
the apparatus.  The apparatus was then cleaned and the barrier was replaced before the animal 
was placed back into the starting arm for the next trial.  A total of 11 trials were given, and the 
choice of arm was recorded in order to calculate total number of perseverations (re-entries to 
same arm) and alternations (entries into the opposite arm).  No time limit was applied, but in the 
rare case of animals that failed to explore one of the upper arms within five minutes, the plastic 
was tapped at the starting end of the apparatus, prodding the animal to progress to the end of the 
apparatus.  Normally, animals are expected to alternate arm entries in order to more fully explore 
the apparatus, while an increased proportion of repetitive responses is reflective of perseverative-
type behaviors. 
Light-Dark Exploration. 
Animals.  A total of 24 IL1-R1 KO mice (12 male, 12 female) and 24 WT mice (12 male, 
12 female) were tested in two cohorts. 
Procedure.  Animals were placed into a rectangular box measuring 45 x 20 x 20 cm, half 
of which was covered and painted black (“dark” side) and the other half of which had no cover 
and was painted white (“light” side).  Animals were placed into the light side and allowed to 
freely explore for five minutes.  Total time spent on the light and dark sides were recorded.  
Latency to enter the dark side of the apparatus was also recorded.  Normally, animals will tend to 
spend more time on the dark side of the apparatus, as they avoid the more open, light, area where 
they are at a greater risk for exposure to predators.  Increased time spent in the dark side of the 
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apparatus is associated with increased anxiety, and freezing behavior is associated with an 
increased latency to exit the light side of the apparatus. 
Porsolt Forced-Swim Test (FST). 
Animals.  A total of 24 IL1-R1 KO mice (12 male, 12 female) and 24 WT mice (12 male, 
12 female) were tested in two cohorts. 
Procedure.  Animals were placed into a small pool (33 x 34 cm) of room-temperature 
water with a water depth of 30 cm and 26.5 cm walls extending above the water’s surface, from 
which they could not escape.  During the training period animals were placed in the center of the 
pool and allowed to explore for 15 minutes.  After 24 hours, the animals were placed in the same 
pool of water for the test session and left to freely explore for five minutes.  Total time spent 
immobile (floating with no escape-related behaviors) was recorded during the test session.  
Increased time spent immobile during the second day of testing is indicative of a learned-
helplessness type response, and associated with a depressive-type condition. 
Social Behavior 
Social Interaction. 
Animals.  A total of 10 IL1-R1 KO animals (5 male, 5 female) and 10 WT animals (5 
male, 5 female) were tested.  Three additional animals (one WT male, one WT female, and one 
KO male) were not tested due to the presence of sores and diminished body weight suggestive of 
poor health. 
Procedure.  Animals were placed in the apparatus previously described above for the 
Open Field Test.  A novel WT (“stranger”) mouse was placed on the center grid square and 
allowed to freely explore the field.  Stranger animals were matched for sex and approximate size 
to the test animal.  Fifteen seconds later the test animal was placed on the center square and both 
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animals were left to explore freely for five minutes.  Social contact behaviors initiated by the test 
animal were recorded, including total number of face-to-face and face-to-body contacts.  The 
latency to first face-to-face contact initiated by the test animals was also recorded.  The number 
of aggressive acts (biting, fighting, etc.) initiated by either animal was recorded.  “Following” 
behavior was recorded as the number of grid crossings made while following the stranger mouse.  
Aggressive acts and following behavior are both considered inappropriate social behaviors, and 
associated with impairments in social functioning. 
Cognitive Functions 
Morris Water Maze (MWM) Acquisition. 
Animals.  A total of 23 IL1-R1 KO mice (12 male, 11 female) and 24 WT mice (12 male, 
12 female) were tested in two cohorts. 
Procedure.  A plastic pool painted with non-toxic white paint measuring 105cm in 
diameter with a water depth of 35cm was placed in a room measuring 1.38 m x 2.13 m with high 
contrast spatial cues on the walls that were kept constant throughout testing.  The water was 
made opaque with non-toxic white paint in order to camouflage a 14 cm round plastic platform 
hidden 2.5 cm below the water surface.  The pool was conceptually divided into four equal 
quadrants, one of which held the hidden platform 10 cm from the pool wall (“goal” quadrant).  
Animals were placed in one of the non-goal quadrants at the start of each trial, in a pseudo-
random order across three trials (a “trial block”).  During acquisition, animals were tested for 
latency to find the platform in the goal quadrant across four to six days, with two or three trial 
blocks per day until control animals achieved criterion latencies of fewer than 10 seconds to 
locate the hidden platform.  Individual cohorts required 9–12 blocks to reach criterion. Animals 
unable to find the platform within 60 seconds were directed to the platform by the experimenter 
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and assigned a latency of 60 seconds for that trial.  In addition to latency measures, mean 
quadrant crossing time was recorded as an estimate of swim speed.  Normally, animals will show 
a decreased latency to find the platform over trial blocks, indicating acquisition of the spatial 
location of the platform. 
Morris Water Maze (MWM) Retention. 
Animals.  A total of 23 IL1-R1 KO mice (12 male, 11 female) and 24 WT mice (12 male, 
12 female) were tested in two cohorts. 
Procedure.  One hour after the final trial block of acquisition, animals were tested for 
retention of goal quadrant location on a spatial probe trial.  The platform was removed and 
animals were placed in the center of the pool facing away from the quadrant that had previously 
contained the escape platform (i.e., the goal quadrant).  Animals were tested for the amount of 
time they spent in each of the four quadrants over a 30-second retention trial.  Normal animals 
will spend proportionally more time in the goal quadrant than the adjacent or opposite quadrants, 
indicating an ability to retain the spatial location of the platform. 
Object Placement. 
Animals.  A total of 23 IL1-R1 KO animals (12 male, 11 female) and 23 WT animals (10 
male, 12 female) were tested in two cohorts.  One additional animal (one WT male) was not 
tested due to the presence of sores and diminished body weight suggestive of poor health. 
Procedure.  Animals were tested in the apparatus previously described above for the 
Open Field Test.  During an initial habituation period, two identical objects (mugs placed on 
their sides) were placed in the field and the animal was left to freely explore for five minutes.  
The animal was then removed while one of the two objects was moved (“novel” object location).  
During the testing phase the animal was reintroduced to the apparatus in the center square, 
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equidistant from each object, and allowed to freely explore for five minutes.  Total time spent 
with each object was recorded to assess spatial novelty recognition.  Animals have a preference 
for exploring novel objects, and are expected to explore the moved object more than the 
stationary object.  A preference for the novel object illustrates learning and recognition 
processes, and a failure to show a preference for the novel object indicates impaired memory 
functions. 
Statistical Analyses 
Most analyses were conducted with separate univariate ANOVA tests to assess 
differences between KO and WT animals for each measure for most behavioral tests.  Animals 
were also tested for changes in performance over time on some measures, in which case a 
repeated measures factor was added to the Factorial ANOVA, making it a mixed Factorial 
ANOVA, as reported in results.  In addition, in some cases a MANOVA test was conducted for 
related measures, also reported in results.  Appropriate alpha adjustments for significant testing 
were made to accommodate for multiple testing. 
Results 
General Activity and Locomotion 
Open Field.  IL1-R1 animals did not significantly differ from WT animals in the total 
number of grid crossings in the open field test [F (1, 40) = 1.965, p = 0.169; see Figure 1].  In 
addition, there were no significant sex differences [F (1, 40) = 0.186, p = 0.669], nor a genotype 
by sex interaction [F (1, 40) = 2.184, p = 0.147].  Therefore, there appear to be no impairments 
in general locomotor functions across the different groups. 
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Gait.  Outlier scores (two or more standard deviations away from the mean) were 
removed for the stride length (one WT male and one WT female), stride width (one WT female 
and one KO female), and interstep distance (two WT females) analyses. IL1-R1 KO animals did 
not significantly differ from WT animals on any of the gait measures, including stride length for 
each paw (see Table 1), stride width (see Table 2) or interstep distance (see Table 3), with no 
significant sex effects, nor genotype by sex interactions (see Figure 2). 
Table 1: Stride Length 
 
  
 
F (df) p 
Genotype 0.358 (3, 123) 0.752 
Sex 0.879 (3, 123) 0.441 
Genotype x Sex 0.177 (3, 123) 0.886 
* significant at the p < .05 level     
 
Table 2:  Stride Width 
 
  
 
F (df) p 
Genotype 0.213 (1, 41) 0.647 
Sex 0.01 (1, 41) 0.923 
Genotype x Sex 0.775 (1, 41) 0.384 
* significant at the p < .05 level     
Figure 1.  Open field total grid crossings for IL1-R1 KO and WT mice.  n = 11–12/ 
group. 
0 
20 
40 
60 
80 
100 
120 
Male Female T
ot
al
 G
ri
d 
C
ro
ss
in
gs
 
WT 
KO 
  
61 
61 
 
Table 3:  Interstep Distance 
 
  
 
F (df) p 
Genotype 1.056(1, 41) 0.310 
Sex 0.753 (1, 41) 0.391 
Genotype x Sex 1.388 (1, 41) 0.246 
* significant at the p < .05 level     
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Figure 2.  Gait measurements of stride length for each paw (A), stride width (B) and 
interstep distance (C) for IL1-R1 KO and WT mice. n = 10–12/group. 
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Facial Morphometrics 
Snout Morphometrics.  Outlier scores for one animal (KO female) were removed from 
both snout morphometric measures.  Female animals had significantly longer snouts than males 
(see Table 4).  However, there were no significant differences between genotypes for snout 
length, nor a significant genotype by sex interaction (see Figure 3 and Table 4).  There were no 
significant differences for philtrum length (distance from the center top edge of the mouth to the 
top of the base of the nose).   
Table 4:  Snout Morphometrics     
  F (df) p 
Philtrum Length     
Genotype 4.212 (1, 19) 0.054 
Sex 4.212 (1, 19) 0.054 
Genotype x Sex 0.468 (1, 19) 0.502 
Snout Length     
Genotype 0.032 (1, 19) 0.860 
Sex 9.272 (1, 19) 0.007* 
Genotype x Sex 0.289 (1, 19) 0.597 
* significant at the p < .05 level     
  
Figure 3.  Snout shape and size, as measured with philtrum length and snout width for 
IL1-R1 KO and WT mice. n = 6/group. 
0 
0.2 
0.4 
0.6 
0.8 
1 
1.2 
1.4 
1.6 
philtrum length snout length 
L
en
gt
h 
(m
m
) 
Male WT 
Male KO 
Female WT 
Female KO 
* 
  
63 
63 
Eye Morphometrics. Outlier scores for one animal (KO female) were removed from all 
eye morphometric measures.  Eye morphometrics were analyzed in a single MANOVA test.  
IL1-R1 KO animals were found to have significantly smaller eyes than the WT animals (see 
Figure 4).  Specifically, IL1-R1 KO animals had a smaller average palpebral fissure length (peak 
distance between the proximal and distal corners of the eye) than WT animals, with no sex or sex 
by genotype interaction (see Table 5).  All other eye measurements were not significant, 
indicating that the placement of the eyes within the face was normal for KO animals. 
Table 5:  Eye Morphometrics     
  F (df) p 
Inner Canthal Distance     
Genotype 0.016 (1, 19) 0.900 
Sex 0.036 (1, 19) 0.851 
Genotype x Sex 1.17 (1, 19) 0.293 
Outer Canthal Distance     
Genotype 2.305 (1, 19) 0.145 
Sex 0.814 (1, 19) 0.378 
Genotype x Sex 0.059 (1, 19) 0.811 
Palpebral Fissure Length 
 
  
Genotype 7.307 (1, 19) 0.014* 
Sex 0.92 (1, 19) 0.350 
Genotype x Sex 0.616 (1, 19) 0.442 
Palpebral Fissure Width     
Genotype 0.243 (1, 19) 0.628 
Sex 0.108 (1, 19) 0.746 
Genotype x Sex 1.729 (1, 19) 0.204 
* significant at the p < .05 level     
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Visual Cliff.  To evaluate whether the reduced eye size in the IL1-R1 KO mice was 
associated with loss of vision, we conducted the visual cliff test as a surrogate screen for 
blindness. There were no significant effects for genotype [F (1, 43) = 0.259, p = 0.613] or sex [F 
(1, 43) = 0.256, p = 0.615], and no genotype by sex interaction [Genotype*Sex:  F (1, 43) = .001, 
p = 0.997] on the proportion of time spent on the cliff side of apparatus.  Thus, despite having 
smaller eyes, we could find no evidence that IL1-R1 KO animals are blind or have functional 
impairments in depth perception (see Figure 5), although we cannot rule out differences in visual 
acuity. 
* * 
Figure 4.  Eye shape and size, as measured with inner canthal distance, outer 
canthal distance, palpebral fissure length, and palpebral fissure width for IL1-R1 
KO and WT mice.  n = 6/group. 
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Emotional Responses 
Open Field.  Outlier scores for two animals (one KO female and one WT male) were removed 
for the latency to exit the center square analyses.  There was a significant genotype by sex 
interaction effect for the latency to exit the center square, but no overall significant main effect 
for genotype or sex on the same measure (see Table 6).  Specifically, WT male animals were 
found to take longer to exit the center square, with a mean latency of 1.9 seconds (SEM = 0.35), 
while all other groups had a mean latency of at least 1.3 seconds faster (see Figure 6). There 
were no significant genotype, sex, or genotype by sex interaction effects for the proportion of 
grid crossings into the center grid square (see Table 7).  In a mixed Factorial ANOVA the 
proportion of crossings across three different time intervals (bins) was also not significant for 
differences by genotype or sex (see Table 8).  Grooming and rearing behavior measures also 
yielded no significant effects (see Tables 9–11). 
 
Figure 5.  Proportion of time spent on the cliff side of the visual cliff apparatus for 
IL1-R1 KO and WT mice.  n = 11–12/group. 
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Table 6:  Open Field Latency to Exit Center Square     
  F (df) p 
Genotype 2.389 (1, 38) 0.131 
Sex 2.389 (1, 38) 0.131 
Genotype x Sex 9.554 (1, 38) 0.004* 
* significant at the p < .05 level     
 
Table 7:  Open Field Inner Crossings     
  F (df) p 
Genotype 0.006 (1, 40) 0.939 
Sex 0.058 (1, 40) 0.811 
Genotype x Sex 0.011 (1, 40) 0.918 
* significant at the p < .05 level     
 
Table 8:  Open Field Bin Crossings     
  F (df) p 
Bin x Genotype 0.74  (2, 80) 0.439 
Bin x Sex 0.634 (2, 80) 0.484 
Bin x Genotype x Sex 1.861 (2, 80) 0.174 
* significant at the p < .05 level     
 
Table 9:  Open Field Latency to First Groom     
  F (df) p 
Genotype 0.258 (1, 40) 0.615 
Sex 0.008 (1, 40) 0.931 
Genotype x Sex 0.038 (1, 40) 0.846 
* significant at the p < .05 level     
 
Table 10:  Open Field Total Grooms     
  F (df) p 
Genotype 0.024 (1, 40) 0.878 
Sex 0.024 (1, 40) 0.878 
Genotype x Sex 0.865 (1, 40) 0.358 
* significant at the p < .05 level     
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Table 11:  Open Field Total Rears     
  F (df) p 
Genotype 0.004 (1, 40) 0.947 
Sex 0.76 (1, 40) 0.388 
Genotype x Sex 0.151 (1, 40) 0.700 
* significant at the p < .05 level     
 
Figure 6.  Open%field%latency%to%first%exit%the%center%square%(A),%proportion%of%inner%grid%crossings%(B),%latency%to%first%groom%(C),%total%grooms"(D),"and"total"rearing"behavior)(E))for)IL1!R1#KO#and#WT#mice.#n = 11–12/group. 
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Elevated Plus.  IL1-R1KO animals did not significantly differ from WT animals on any 
of the elevated plus measures, including the proportion of time spent on the closed arms, open 
arms, or the central platform (see Tables 12–14).  There were also no significant sex effects or 
genotype by sex interactions for any of the three measures (see Figure 7). 
Table 12:  Proportion of Time in Open Arms     
  F (df) p 
Genotype 0.946 (1, 42) 0.336 
Sex 0.01 (1, 42) 0.921 
Genotype x Sex 2.229 (1, 42) 0.143 
* significant at the p < .05 level   
 
Table 13:  Proportion of Time in Closed Arms     
  F (df) p 
Genotype 0.464 (1, 42) 0.499 
Sex 0.009 (1, 42) 0.925 
Genotype x Sex 2.303 (1, 42) 0.137 
* significant at the p < .05 level   
 
Table 14:  Proportion of Time on Central Platform     
  F (df) p 
Genotype 0.149 (1, 42) 0.701 
Sex 0.067 (1, 42) 0.797 
Genotype x Sex 1.358 (1, 42) 0.250 
* significant at the p < .05 level   
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Novelty-Suppressed Feeding.  There was a significant sex by genotype interaction for 
both the total number of approaches made towards the food and the total number of entries into 
the center grid square, with no significant main effects for either genotype or sex on either of 
these measures (see Tables 15 and 16).  Both of the significant interactions showed that male 
IL1-R1 KO animals made more entries into the middle square, approaching the novel food 
stimulus, than the WT males, while the inverse pattern was found with the female animals (see 
Figure 8). These data suggest either enhanced reward-motivated exploratory drive or decreased 
anxiety in the male KO mice.  No significant effects were found for the two latency measures 
(latency to first sniff or bite of the novel food stimulus) or the latency to first enter the center grid 
square (see Tables 17 and 18). 
 
 
 
Figure 7.  Proportion of time spent in the open arms, closed arms, or central platform 
of the elevated plus maze apparatus for IL1-R1 KO and WT mice.  n = 11–12/group. 
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Table 15:  Total Sniffs or Bites     
  F (df) p 
Genotype 0 (1, 18) 0.989 
Sex 0.445 (1, 18) 0.513 
Genotype x Sex 4.45 (1, 18) 0.049* 
* significant at the p < .05 level     
 
Table 16:  Total Center Square Entries     
  F (df) p 
Genotype 0.795 (1, 18) 0.384 
Sex 0.065 (1, 18) 0.802 
Genotype* x Sex 5.858 (1, 18) 0.026* 
* significant at the p < .05 level     
 
Table 17:  Latency to First Sniff or Bite     
  F (df) p 
Genotype 0.159 (1, 18) 0.659 
Sex 0.009 (1, 18) 0.927 
Genotype x Sex 0.024 (1, 18) 0.878 
* significant at the p < .05 level     
 
Table 18:  Latency to Enter Center Square     
  F (df) p 
Genotype 0.866 (1, 18) 0.790 
Sex 1.544 (1, 18) 0.230 
Genotype x Sex 0.866 (1, 18) 0.364 
* significant at the p < .05 level     
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Figure 8.  Total sniffs or bites (A), total center square entries (B), mean latency to 
sniff or bite (C), and mean latency to enter the center square in the novelty-suppressed 
feeding test for IL1-R1 KO and WT mice. n = 5–6/group/ 
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Y-Maze.  IL1-R1 KO animals were not found to differ significantly from WT animals in 
the proportion of perseverative-type responses in the Y-maze [F (1, 19) = 0.350, p = 0.561].  
There was also no significant effect for sex [F (1, 19) = 0.014, p = 0.907], nor a significant 
genotype by sex interaction [F (1, 19) = 1.695, p = 0.209]. 
 
Light-Dark.  The proportion of time spent on the light side of the apparatus did not 
significantly differ by genotype [F (1,43) = 0.267, p = 0.608] or sex [F (1, 43) = 0.536, p = 
0.468], and there was no significant genotype by sex interaction [F (1, 43) = 0.428, p = 0.517]. 
Figure 9.  Proportion of perseverative responses for IL1-R1 KO and WT mice in the 
Y-maze.  n = 5–6/group. 
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Porsolt Forced-Swim Test (FST).  There was a significant overall main effect for the 
cohort variable in the FST [F (1, 40) = 8.456, p = 0.006], but no significant interactions with 
cohort, suggesting that the baseline measurements of time spent immobile were different 
between the two cohorts.  Specifically, the first cohort, on average, spent more time immobile on 
day two in the apparatus (M = 189.292, SEM = 8.825) than the second cohort (M = 153.00, SEM 
= 8.825). Therefore, a cohort adjustment (correction) was made by adding 40 seconds to each 
data point in the second cohort, regardless of sex or genotype, to allow cohorts to be combined 
for an analysis of genotype and sex effects.  These adjusted values revealed a significant 
genotype by sex interaction [F (1, 44) = 4.436, p = 0.041], with no overall significant main 
effects for genotype [F (1, 44) = 2.240, p = 0.142] or sex [F (1, 44) = 0.548, p = 0.463].  A 
simple effects analysis further revealed KO females spent more time immobile than WT females 
[F (1, 44) = 6.491, p = .014], while KO and WT males did not significantly differ from one 
Figure 10.  Proportion of time spent on the light side of the light-dark apparatus for 
IL1-R1 KO and WT mice. n = 11–12/group. 
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another [F (1, 44) = 0.189, p = .669], suggesting female KO animals had more learned 
helplessness. 
 
Social Behavior 
Social Interaction.  IL1-R1 KO animals were not found to significantly differ from WT 
animals across all social contact behaviors (latency to first face-to-face contact, total face-to-face 
contacts, and total face-to-body contacts) or atypical behaviors (total aggressive acts and 
following), see Tables 19–23. 
Table 19:  Latency to First Face-to-Face Contact     
  F (df) p 
Genotype 0.332 (1, 16) 0.573 
Sex 1.521 (1, 16) 0.235 
Genotype x Sex 0 (1, 16) 0.997 
* significant at the p < .05 level     
 
 
Figure 11.  Time immobile in the FST for younger IL1-R1 KO and WT mice.  Mean 
values are adjusted for cohort effect.  n = 12/group. 
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Table 20:  Total Face-to-Face Contacts     
  F (df) p 
Genotype 1.69 (1, 16) 0.212 
Sex 1.69 (1, 16) 0.212 
Genotype x Sex 1.69 (1, 16) 0.212 
* significant at the p < .05 level     
 
Table 21:  Total Face-to-Body Contacts     
  F (df) p 
Genotype 0.336 (1, 16) 0.570 
Sex 0.013 (1, 16) 0.909 
Genotype x Sex 0.013 (1, 16) 0.909 
* significant at the p < .05 level     
 
Table 22:  Total Aggressive Acts     
  F (df) p 
Genotype 0.86 (1, 16) 0.368 
Sex 0.158 (1, 16) 0.696 
Genotype x Sex 0.86 (1, 16) 0.368 
* significant at the p < .05 level     
 
Table 23:  Following Behavior     
  F (df) p 
Genotype 0.164 (1, 16) 0.691 
Sex 0.018 (1, 16) 0.894 
Genotype x Sex 0.018 (1, 16) 0.894 
* significant at the p < .05 level     
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Figure 12.  Mean latency to first face-to-face contact (A), total face-to-face and face-
to-body contacts (B), and total aggressive acts and grids crossed while following (C) 
in the social interaction test for IL1-R1 KO and WT mice. n = 5/group. 
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Cognitive Functions 
Morris Water Maze (MWM) Acquisition.  A mixed Factorial ANOVA revealed a 
significant overall main effect for the mean latency to find the platform across the different 
testing blocks [F (1, 215) = 36.828, p = 0.001], indicating that animals learned across time.  The 
latency to escape varied by genotype, with a significant block by genotype interaction [F (1, 215) 
= 2.881, p = 0.026], in which IL1-R1 KO animals were equivalent to WT animals in the first 
testing block, but overall took longer to find the platform as the trial blocks progressed, 
indicating impaired learning for the location of the platform.  The IL1-R1 KO male animals 
primarily drove this effect, as the KO females were very similar to the WT females and WT 
males in the later trial blocks.  There was no significant three-way trial block by genotype by sex 
interaction [F (1, 215) = 0.876, p = 0.477], but there was a significant trial block by sex 
interaction [F (1, 215) = 2.472, p = 0.048], with male animals showing overall longer latencies to 
escape than female animals; however, this was again primarily driven by the IL1-R1 KO males, 
who failed to show the same level of learning to find the platform across the later blocks.  An 
estimated measure of swim speed, based on the number of quadrant crossings made per trial 
block, yielded a significant effect for trial block [F (1, 215) = 7.422, p = 0.001] and for trial 
block by sex interaction [F (5, 215) = 3.533, p = 0.006], with female animals showing a faster 
swimming speed as trials progressed while male animals did not show such an increase.  
However, there was no trial block by genotype interaction [F (5, 215) = 1.383, p = 0.232], nor 
block by genotype and sex interaction [F (5, 215) = 0.369, p = 0.848].  A separate ANOVA test 
of the mean latency to find the platform on the first trial block revealed no genotype by sex 
interaction [F (3, 41) = 0.508, p = 0.489], indicating no initial differences in performance.  A 
separate repeated measures ANCOVA was conducted to factor out the influence of estimated 
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swim speed on the latency to find the platform across trial blocks, revealing a significant 
genotype by trial block interaction [F (5, 185) = 2.626, p = .041} such that WTs performance 
improved more quickly than the Kos.  However, the previously significant sex by trial block 
interaction effect was lost when estimated swim speed was covaried out of the analysis [F (5, 
185) = 1.042, p = .185).  The covariance analysis also revealed no three-way trial block by sex 
and genotype interaction [F (5, 185) = 0.817, p = .509].  Therefore, when taking into account sex 
differences in estimated swim speed, IL1-R1 KO animals had overall poorer learning for the 
location of the platform as trials progressed when compared to WT animals. 
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Morris Water Maze (MWM) Retention.  IL1-R1 KO animals were found to spend 
significantly less time in the goal quadrant than WT animals during a retention testing trial [F (1, 
43) = 4.590, p = 0.038], with a significant genotype by sex interaction [F (1, 43) = 22.004, p = 
0.001].  Similar to the findings in the MWM acquisition test, male IL1-R1 KO animals had poor 
Figure 13.  Mean latency to find the platform (A) and estimated swim speed (B) 
across trial blocks during MWM acquisition for younger IL1-R1 KO and WT mice.    
n = 11–12/group. 
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retention for the location of the removed platform.  This may reflect poor retention skills, but 
more likely reflects a failure to learn the position of the platform in the original acquisition task.  
There was no significant sex effect [F (1, 43) = 42.197, p = 0.146]. 
 
 
Object Placement.  The proportion of time spent exploring the object in a novel location 
did not differ across genotype [F (1, 42) = 0.118, p = 0.733] or sex [F (1, 42) = 1.975, p = 0.167], 
and there was no significant genotype by sex interaction [F (1, 42) = 1.114, p = 0.297]. 
* 
Figure 14.  Proportion of total time spent in the goal quadrant in MWM retention test 
for younger IL1-R1 KO and WT mice.  n = 11–12/group. 
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Discussion 
Because IL-1 plays an important role in the inflammatory response, including sickness 
behavior and changes in emotional and cognitive functions, IL1-R1 KO animals were tested on a 
broad array of behavioral tests.  Findings revealed that IL1-R1 KO animals have normal general 
activity and locomotor functions, but some abnormalities in facial morphometry, as well as 
selective cognitive and emotional abnormalities. 
Consistent with prior research (e.g., Koo & Duman, 2009), IL1-R1 KO mice and WT 
mice did not differ in their general locomotor activity, as measured by the total number of grids 
crossed in the open field test.  In addition, multiple gait measurements fell within a normal range.  
However, facial morphometry measures revealed that KO animals having a shorter mean 
palpebral fissure length.  As a follow-up, animals were tested on the visual cliff apparatus and 
were found to have normal depth perception.  Therefore, although KO animals were found to 
have smaller eyes, they appeared not to be blind and had no detectable visual impairment for 
depth perception. Visual acuity was not tested, so it cannot be assumed KO animals have 
completely normal visual functions.  In addition to the smaller eye size, there was a non-
Figure 15.  Proportion of total time spent with a novel object in the object placement 
test for IL1-R1 KO and WT mice.  n = 11–12/group. 
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significant trend for IL1-R1 KO animals to have a shortened philtrum length, indicating a shorter 
snout. The findings of facial morphological abnormalities were not expected, but were consistent 
with findings that IL-1 is important in prenatal development and postnatal bone growth (MacRae 
et al., 2007). 
IL1-R1 KO animals did not differ from WT animals in social behaviors.  These findings are 
important, as sickness behavior associated with increases in IL-1 activity includes a reduction in 
social interactions (Bison et al., 2009).  Thus, along with the failure to find general changes in 
locomotion, we have ruled-out the influence of potential sickness-type behaviors in the WT animals 
when interpreting other behavioral findings. 
Generally, IL1-R1 KO animals were found have reduced anxiety levels across multiple 
tests, most pronounced in male animals. However, findings were mixed across different measures of 
anxiety-type behaviors.  In the open field test, KO males were more similar to KO and WT females 
than they were to WT males, who had a significantly longer latency to exit the center square.  Male 
KO animals were also found to have a reduced anxiety-type response in the novelty-suppressed 
feeding test, where the drive to explore a food source is inhibited by the placement of the food in an 
exposed open field.  In this case, the KO male animals were found to enter the center of the open 
field and either sniff or bite the food less often when compared to WT animals.  Yet again, females 
had the opposite response, with reduced center square entries and sniffs or bites of the food source, 
consistent with a heightened anxiety response.   
Both Koo and Duman (2009) and Murray et al. (2013) also found a decreased anxiety 
response for IL1-R1 KO animals, but using different test measures.  Koo and Duman found reduced 
anxiety in male IL1-R1 KO animals in the elevated plus maze and the light-dark test.  Murray found 
reduced anxiety in both female and male IL1-R1 KO animals in the elevated plus maze and the 
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open field test.  Murray’s findings are also open to interpretation, as they found IL1-R1 KO animals 
had more total grid crossings and rearing behaviors than WT animals, and failed to record measures 
of activity in and out of the central grid square.  In the context of finding a decreased anxiety 
response in the elevated plus maze, they concluded the higher number of grid crossings and rearing 
behavior were indicative of decreased anxiety.  However, these behavioral patterns may also reflect 
an overall increase in general activity instead of reduced anxiety.   
The current study failed to reveal any significant differences for either the elevated plus 
maze or the light-dark test of these behavioral tests, and only male IL1-R1 KO animals were found 
to have a reduced anxiety-type response in the open field apparatus.  While the pattern of results for 
the male KO animals was consistent with prior reports; we were unable to fully replicate prior 
findings. This may reflect differences in protocols, including the physical structure of the apparatus, 
measurement tools, or animal ages, as Koo and Duman (2009) report their animals were adult 
males, but do not provide specific ages. 
Evaluation of depressive-type behavior also revealed a sex-specific genotype effect, as IL1-
R1 female KO animals spent more time immobile in the FST when compared to male KO animals 
and both female and male WT animals.  Koo and Duman (2009) failed to find a difference for WT 
and IL1-R1 KO animals using a similar procedure, but only tested male animals.  Our data replicate 
their finding of no differences between male WT and male IL1-R1 KO animals on the FST, but 
extend the findings to an observation that female KO animals have increased learned helplessness-
like behaviors. 
IL1-R1 animals were found to have impaired learning and memory functions in the MWM.  
During the acquisition phase, KO animals failed to learn to find the hidden platform, as indicated by 
slower latencies in the later test trials.  Sex-differences in this effect were apparent, but were no 
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longer observed when an estimate of swim speed was covaried out of the analysis across all 
animals.  One interpretation of these findings is that KO animals had impaired locomotor functions 
when swimming.  In fact, there was a significant sex-difference in estimated swim speed, with 
males swimming more slowly than females.  However, there was no sex by genotype interaction for 
swim speed, indicating the slowed latencies in the acquisition phase were not specific to KO males, 
and further supported by the finding of an overall effect for genotype when swim speed estimates 
were covaried out for the latency measure.  Thus, the impaired learning for KO animals can 
probably not be attributed fully to their slower swim speed.  While the acquisition phase of the 
MWM revealed no difference for male and female KO animals in their learning of the location of 
the platform, performance in the retention phase indicate male KO animals had a more profound 
learning impairment than females.  Male KO animals showed no retention for the location of the 
platform, which could indicate an impairment of memory processes, but more likely reflects an 
initial impairment in learning the location of the platform in the acquisition phase.  These 
impairments in spatial learning and memory performance parallel those in prior findings with IL1-
R1 KO male mice (Avital et al., 2003), supporting Yirmiya et al.’s (2002) assertion of an optimal 
level of IL-1 activity for normal spatial learning and memory functions, with impairments at both 
abnormally low and high levels of IL-1 activity.  It should be noted Murray et al. (2013) failed to 
find impaired spatial learning in the MWM for female IL1-R1 KO animals.  These findings are also 
consistent with our findings, as male animals primarily drove the impaired learning and retention 
performance observed for IL1-R1 KO animals.   
A broad phenotyping battery of IL1-R1 KO animals revealed a pattern of overall decreased 
anxiety behaviors, especially for males, and an increased depressive-type response in females, along 
with impaired learning and memory functions for males.  The finding of sex-based differences is 
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particularly important, as most prior research on the importance of IL-1 activity for emotional 
and cognitive behaviors in animals have been restricted to male-only or separated male and 
female populations.  At the same time, other research has pointed to consistent findings of sex-
based differences in hippocampal function and stress responses in rodent populations (Falconer 
& Galea, 2003; Shors et al., 2007).  These differences could be attributed to a number of 
potential factors such as differential developmental influences or the actions of circulating 
gonadal hormones.  Hormone-mediated differences are subject to change or resolution with 
older-aged populations in which females experience decreases in levels of circulating ovarian 
hormones (e.g., Brummelte & Galea, 2010).  At the same time, aged populations are at an 
increased risk for mood disorders and cognitive impairments (Kanowski, 1994; Korcyz & 
Halperin, 2009).  Given that aged populations are also at risk for increased neuroinflammation 
(Cerejeirae et al., 2010), a second AIM of the current study focused on a specific subset of 
behavioral tests to be tested on both male and female IL1-R1 KO animals at an older age. 
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CHAPTER 4:  SPECIFIC AIM 2 
Specific Aim 2 was to explore potential age-related changes in learning and memory in male 
and female IL1-R1 knock out (KO) mice, as well as for emotional differences found for 
younger animals, to determine if impairments persist or worsen with age. 
In Aim 1 a broad phenotyping battery showed that IL1-R1 KO mice differed from WT mice 
in their emotional responses and cognitive functions.  In addition, some of the effects were sex-
specific or sex-preferential. KO mice showed a general pattern of reduced anxiety responses, 
especially in males, while only female KO animals had increased depressive-type behaviors.  IL1-
R1 KO mice also had impaired spatial learning and memory skills, again, with sex-based 
differences.  This pattern of findings was consistent with prior research testing male IL1-R1 KO 
mice (e.g., Koo & Duman, 2008 & 2009), and the general finding that IL-1 activity is important for 
optimal hippocampal function and regulation of immunological processes related to the stress 
response (e.g., Dunn, 2000; Avital et al., 2003).  However, the observed sex-based differences in 
Aim 1 illuminate the potential importance of circulating ovarian hormones in helping to regulate or 
modulate IL-1 activity, which has not been observed in prior studies with both male and female 
IL1-R1 KO mice (Murray et al., 2013).  In addition, prior studies have failed to look at changes in 
performance across the lifespan.  Badowska-Szalewksa et al. (2009) found an age-related decline in 
IL-1 activity within the hippocampus and amygdala in a chronic stress response for rats, 
highlighting the importance of studying the influence of IL-1 activity in older-aged animals. 
The second Aim of the current study explored potential age-related changes in emotional 
and cognitive functions in male and female IL1-R1 KO mice, by retesting animals on a subset of 
behavioral tests with a minimum of six months between younger and older testing sessions. 
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Specific Methods 
Animals 
Animals were retested between 11 and 13 months of age on the FST and the MWM test 
(acquisition and retention phases). 
Porsolt Forced-Swim Test (FST).  A total of 11 IL1-R1 KO animals (6 male, 5 female) 
and 11 WT animals (5 male, 6 female) were tested from a single cohort in the FST.  Two 
animals, one WT male and one IL1-R1 KO female, were excluded from testing at this age due to 
illness or injury. 
Morris Water Maze (MWM) Test.  A total of 23 IL1-R1 KO animals (12 male, 11 
female), and 22 WT animals (10 male, 12 female) were tested across two cohorts in the MWM 
acquisition and retention trials.  Two additional animals (WT males) were not tested due to the 
presence of sores and diminished body weight suggestive of poor health or poor swimming 
ability.  The procedure for testing animals at the older age was the same, but with the platform 
moved to a different quadrant to avoid the influence of any prior learning from previous testing 
at a younger age. 
Procedure 
All behavioral testing procedures followed the same protocols outlined in Aim 1, unless 
otherwise noted in the Results below. 
Statistical Analyses 
Univariate ANOVA tests were conducted on just the aged animals for each behavioral test 
to assess for differences between KO and WT animals at an older age.  Additional mixed Factorial 
ANOVA tests were also conducted to compare younger and older aged animal testing performance, 
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where possible.  Appropriate alpha adjustments for significance testing were made to 
accommodate for multiple testing. 
Results 
Emotional Responses 
Porsolt Forced-Swim Test (FST).  An initial ANOVA for the testing of the animals at 
an older age revealed no significant effects for genotype [F (1, 24) = 0.641, p = 0.433], sex [F (1, 
24) = 0.004, p = 0.949], or a genotype by sex interaction [F (1, 24) = 0.118, p = 0.735], see 
Figure 16. 
 
A separate mixed Factorial ANOVA was conducted to compare the effects across the 
different ages for testing. There were no significant main effects for age, genotype, or sex in the 
time spent immobile on the second day in the apparatus (see Table 24).  In addition, neither 
genotype nor sex interacted significantly with age, or a significant age by genotype and sex 
interaction (see Figure 17). 
Figure 16.  Time spent immobile in the FST for older IL1-R1 KO and WT mice. n = 
5–6/group. 
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Table 24: FST     
 F (df) p 
Age 0.593 (1, 18) 0.451 
Genotype 0.231 (1, 18) 0.637 
Sex 0.770 (1, 18) 0.392 
Age x Genotype 0.081 (1, 18) 0.780 
Age x Sex 3.641 (1, 18) 0.072 
Age x Genotype x Sex 3.273 (1, 18) 0.087 
* significant at the p < .05 level   
 
Cognitive Functions 
 
Morris Water Maze (MWM) Acquisition.  A repeated measures ANOVA for just the 
older aged animal testing trials yielded the expected significant overall main effect for trial block 
[F (5, 205) = 15.377, p = 0.001], indicating that animals learned the location of the platform over 
the course of the different trial blocks.  There was also a significant block by genotype 
interaction [F (5, 205) = 2.644, p = 0.034], with IL1-R1KO animals having longer latencies 
Figure 17.  Time spent immobile in the FST for IL1-R1 KO and WT mice tested at 
both a younger and an older age.  n = 5–6/group. 
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towards the later trial blocks, as well as a significant block by sex interaction effect [F (5, 205) = 
4.637, p = 0.038], with male animals having longer latencies towards the later trial blocks.  Both 
the genotype and sex interaction effects with the trial block seemed to be driven by particularly 
poor performance by the male IL1-R1 KO animals, but there was no significant trial block by 
genotype by sex interaction [F (5, 205) = 1.133, p = 0.342], perhaps reflecting the large degree 
of variability in performance across all groups.  The overall pattern of results is similar to those 
found for the same animals tested at a younger age (see AIM 1), but with a higher degree of 
variability (see Figure 18).  An estimated measure of swim speed, based on the number of 
quadrant crossings made per trial block, yielded significant interactions for trial block by 
genotype [F (5, 205) = 3.655, p = 0.009] and trial block by sex [F (5, 205) = 6.326, p = 0.001], 
but no significant interaction of trial block by genotype by sex [F (5, 205) = 1.302, p = 0.264].  
These findings show IL1-R1 animals had a slower estimated swim speed than WT animals, and 
male animals swam more slowly than female animals (see Figure 19). A separate repeated 
measures ANCOVA was conducted to factor out the influence of estimated swim speed on the 
latency to find the platform across trial blocks.  The previously significant genotype by trial 
block interaction effect was lost when estimated swim speed was covaried out of the analysis [F 
(5, 175) = 0.883, p = .476], as was the significant sex by trial block interaction [F (5, 175) = 
2.347, p = .058].  The covariance analysis also revealed no three-way trial block by sex and 
genotype interaction [F (5, 175) = 1.125, p = .347].  However, a separate ANOVA revealed no 
significant genotype [F (1, 41] = 0.940, p = .338], sex [F (1, 41) = 0.297, p = .589], nor sex by 
genotype interaction [F (1, 41) = 0.827, p = .368] effects for estimated swim speed in the first 
trial block.  Therefore, IL1-R1 KO animals had overall poor learning of the location of the 
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platform as trials progressed when compared to WT animals, but these effects also reflect a 
reduced estimated swim speed for KO animals in later trials. 
Therefore, there is no indication of an inherent swim deficit, and the slower swim speed 
for the KO animals relative to the WT animals probably reflects a more aimless swimming 
pattern when searching for the hidden platform.  Overall, the pattern of findings is similar to 
those found with the same animals when tested at a younger age, but with greater variability. 
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Figure 18.  Mean latency to find the platform for older (A) and younger (B) IL1-R1 
KO and WT mice during MWM acquisition.  n = Measurement for (A), and (B) (C) 
for IL1-R1 KO and WT mice. n = 10–12/group. 
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Morris Water Maze (MWM) Retention.  In an ANOVA test for just the older testing 
session, IL1-R1 KO animals were found to spend significantly less time in the goal quadrant 
during the probe trial than WT animals [F (1, 45) = 10.620, p = 0.002], similar to the effect 
found during previous testing at a younger age (see AIM 1).  While there was a significant 
genotype by sex interaction for the animals at a young age (see AIM 1), the effect was not 
Figure 19.  Estimated swim speed for older (A) and younger (B) IL1-R1 KO and WT 
mice during MWM acquisition.  n = 10-12/group. 
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significant during the older aged test [F (1, 45) = 3.408, p = 0.072].  There was no main effect of 
sex for the older animals [F (1, 45) = .256, p = 0.616]. 
A separate repeated measures ANOVA was conducted for the combined data from both 
younger and older aged testing.  There was a significant main effect of genotype, such that IL1-
R1 KO animals spent less time in the goal quadrant than WT animals (see Table 25), but no 
significant main effects for age or sex. There were significant interactions between age, 
genotype, and sex (see Table 25).  An additional simple linear regression analysis was conducted 
to predict older animal retention performance based on younger animal retention performance, 
yielding a non-significant regression equation [F (1, 20) = 1.157, p = .295], with an R2 of .055 
Table 25: MWM Retention   
  F (df) p 
Age 0.899 (1, 41) 0.349 
Genotype 13.538 (1, 41) 0.001* 
Sex 2.161 (1, 41) 0.149 
Age x Genotype 1.476 (1, 41) 0.231 
Age x Sex 0.51 (1, 41) 0.479 
Age x Genotype x Sex 2.214 (1, 41) 0.144 
* significant at the p < .05 level   
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Discussion 
IL1-R1 KO mice were retested on a subset of behavioral tests that previously found to 
reveal significant genotype and sex effects in emotional and cognitive functions to assess any 
longitudinal changes across the lifespan.  Some differences were observed with older IL1-R1 KO 
animals, but with many of the prior effects being reduced or no longer present when compared to 
the findings of Aim 1. 
Testing of depressive-type behavior revealed no difference between IL1-R1 KO mice and 
WT mice at an older age, nor any genotype or sex-based differences.  Despite the finding of an 
increased response in younger female KO animals in Aim 1, repeated tested at a later age 
revealed no age-related differences.  Generally, the lack of findings reflects issues of decreased 
power and increased variability.  Across all testing, older animals were more variable in their 
performance, consistent with well-established findings of increased heterogeneity in rodent 
behavior with aged animals (see van der Staay, 2002, for a review), due to a range of age-related 
Figure 20.  Proportion of total time spent in the goal quadrant in the MWM probe 
retention trial for IL1-R1 KO and WT mice. n = 11-12/group. 
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factors that can variably affect developmental outcomes, including housing conditions, 
sensorimotor impairments, and motivational factors.  In addition, only one of the two cohorts 
was tested at an older age in the FST, potentially leaving too small of a sample size to detect 
differences due to insufficient power. 
Older mice were also not found to differ in the learning of the location of a hidden 
platform in the MWM.  Previously, in Aim 1, genotype and sex effects were found for younger 
animals, with impaired learning for IL1-R1 KO animals, especially males.  A similar pattern was 
observed with older animals, but failed to reach significance, due to the increased overall 
variability of behavior in aged animals. It should also be noted for both the FST and the MWM 
water temperature was not measured and may have varied with changes in room ambient 
temperature across different test sessions.   
Aging is associated with an increase in neuroinflammation, including increased IL-1 
activity within the hippocampus, and has a negative impact on MWM performance (Moore et al., 
2009).  IL1-R1 KO animals may have a reduced inflammatory response when aging due to their 
impaired IL-1 activity, as reflected in the similar flat learning curve found for the IL1-R1 KO 
males for both younger and older aged MWM acquisition performance.  On the other hand, the 
possible protective functions of circulating ovarian hormones may be on the decline in the older 
females, but not sufficiently low enough to impair learning performance in the older IL1-R1 KO 
animals.  In fact, animals in the current study were age 11 to 12 months at the time of retesting in 
the MWM, and prior research has indicated C57BL/6J female mice do not reach complete loss of 
the estrous cycle until 13-18 months, on average (Frick, Burlingame, Delaney, & Berger-
Sweeney, 2002).  This same point may also be significant in interpreting the previous finding of 
no increase in depressive-type behaviors in older IL1-R1 KO female mice. That is, it is possible 
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that the elevated learned hormone-related mediators drove helplessness-like response of the 
younger KO females. 
While IL1-R1 KO animals were not found to have overall significantly impaired learned 
performance in the older test trials, they did have a significantly impaired performance in the 
retention phase of the MWM task.  Typically, unimpaired acquisition and impaired retention 
would indicate a problem with the retention of a spatial memory.  In this instance the results are 
not as clear, as younger IL1-R1 KO animals had a similar pattern of poor retention after an 
impaired learning trial, consistent with never having learned the location of the platform.  
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CHAPTER 5:  SPECIFIC AIM 3 
Specific Aim 3 was to investigate possible neuroanatomical effects of IL1-R1 null mutation, 
including differences in gross anatomy and morphology and distribution of microglial cell 
populations and vasculature in the hippocampus. 
In the first two Aims of the current thesis, IL1-R1 KO animals were found to differ from 
WT animals on behavioral measures of anxiety, depression and spatial learning and memory.  
Repeated testing at a later age revealed increased heterogeneity in performance, reducing the 
statistical magnitude of the differences between KO and WT animals.  Despite this increased 
variability across all groups, there was still evidence of impaired spatial memory performance for 
IL1-RI KO animals.  Importantly, genotype differences were also found to be sex-dependent in 
several measures, especially for younger animals.  In a third Aim, to better understand the nature of 
the noted behavioral changes, neuroanatomical measures were assessed and correlated to specific 
behavioral findings. 
First, gross anatomy of the brain and gross structural organization of hippocampal regions 
were evaluated to assess any notable differences between IL1-R1 KO animals and WT animals, also 
taking into consideration any sex differences.  Previously Murray et al. (2013) found no differences 
between IL1-R1 KO mice and WT mice in ventricular volume, but the researchers were limited to 
looking at the brains of six animals, and all were female.  
Second, vascular morphology and investment were assessed.  Both pathogen-induced and 
age-related increases in neuroinflammatory levels have been associated with changes in 
cerebrovascular functioning, and vascular insufficiency has been reported in humans with cognitive 
or depressive symptoms (see Fountoulakis, Siamouli, Magiria, & Kaprinis, 2007, for a review).  It 
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is therefore reasonable to hypothesize that IL1-R1 KO animals found to have altered cognitive and 
emotional behavior patterns may also display atypical hippocampal vasculature.   
Third, general morphology and distribution of microglial cell populations within the 
hippocampus were assessed.  Microglia play a significant role in the production and regulation of 
IL-1β in the CNS, acting as both a target and source of IL-1β activity.  In their active state, 
microglia have a larger cell body with shorter processes (Dheen, Kaur, & Ling, 2007), and express 
caspase-1, the enzyme critical for cleaving pro-IL-1 into its active form (Erikkson et al., 1999).  
Circulating IL-1β is then able to continue activating microglia through the IL-1 receptors found on 
the surface of microglia, producing a type of feedback loop for increasing IL-1 levels beyond the 
initial acute stage of inflammation (Kaushik, Thounaojam, Kumawat, Gupta, & Basu, 2013).  Given 
that normal aging is associated with an increased neuroinflammatory state, including an increase in 
circulating IL-1β, it is not surprising healthy aged individuals are also found to have an increase in 
activated microglia populations (Dilger & Johnson, 2008).  This increase in base level of activated 
microglia could contribute to the increased vulnerability to cognitive impairment and disease among 
aged populations (Dilger & Johnson, 2008).  In fact, it has been suggested that microglia directly 
contribute to the cognitive decline associated with not only normal healthy aging, but also 
dementing conditions (Li, Liu, Barger, & Griffin, 2003).  Autopsies of AD patients have found 
amyloid plaques, the hallmark of AD, are often surrounded by fields of activated microglia 
(Perlmutter, Scott, Barrón, & Chui, 1997).  These microglia have been suggested to play a 
significant role in the development of the amyloid plaques through the release of IL-1 that 
contributes to tau phosphorylation central to plaque formation (Li, Liu, Barger, & Griffin 2003).   
Given that IL1-R1 KO animals have reduced cytokine (i.e. IL-1) activity, it may be expected they 
would have fewer activated microglia, helping to explain the impaired learning and memory 
  
100 
100 
performance of these animals.  Prior research found no differences between WT and IL1-R1 KO 
male mice in the early activation of microglia following the introduction of chemically induced 
injury to the hippocampus  (Harry, Funk, d’Hellencourt, McPherson, & Aoyama, 2008).   However, 
these researchers only studied weanling male animals and did not look at hippocampal regions of 
animals that did not undergo a surgical procedure.   
Specific Methods 
Animal Sacrifices 
Animals were deeply anesthetized and overdosed with chloral hydrate-pentobarbital, 
exsanguinated, and perfused transcardially with heparinized 0.9% saline followed by 4% 
paraformaldehyde, first in acetate buffer (pH 6.5) and then 4% paraformaldehyde in borate 
buffer (pH 9.5).  After fixation, brains were removed and post-fixed overnight before being 
transferred to 30% sucrose in borate buffer at 4° C for three to ten days. 
Tissue Processing 
Following immersion in the sucrose borate buffer solution, brains were frozen and 
coronally sectioned at 50 µm on a sliding microtome and stored at -20° C in cryoprotectant 
solution as in Watson, Wiegand, Clough, and Hoffman (1986). 
Histology 
Mouse brain sections were mounted on gelatin-coated slides and allowed to dry for three 
days.  Slides were stained using the manual regressive Hematoxylin and Eosin (H&E) method 
for visualizing general tissue structure.  Slides were dipped in a xylenes solution, dehydrated in 
ethyl alcohol, and rehydrated in tap water before staining in Harris Hematoxylin.  Tissue was 
then rinsed in tap water, dehydrated in ethanol, and rehydrated in tap water with a rinse in 0.25% 
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ammonia water prior to counterstaining in 1% eosin solution.  Finally, tissue was dehydrated in 
ethanol and xylenes prior to coverslipping. 
Immunohistochemistry 
Mouse brains were immunostained to visualize the microglial marker ionized calcium 
binding adapter molecule 1 (Iba1), using a rabbit polyclonal primary antibody against Iba1 
(1:1000 dilution; Millipore) and a biotinylated goat anti-rabbit secondary antibody (Vector 
Labs). Microglia were visualized using a diaminobenzidine (DAB) chromagen and a Vector Elite 
ABC kit (Vector Labs). Stained sections were then mounted on gelatin-coated slides, which were 
dehydrated in graded ethanols and cover-slipped after immersion in xylenes. 
Tissue Analysis 
Image Capturing and Analysis.  Stained sections were placed under a Zeiss light 
microscope, and the hippocampal region was viewed and images were captured using Spot 
Digital Imaging software (Diagnostic Instruments, Sterling Heights, MI).  Quantitative image 
analysis was conducted using Image J software (National Institutes of Health, Bethesda, MD). 
Gross Anatomy and Structural Abnormalities of Hippocampal Regions.  H&E 
stained cross-sections of the brain at the level of the hippocampus were observed for gross 
structural abnormalities for each animal in the second testing cohort, for a total of 11 WT (6 
male, 5 female) and 7 IL1-R1 KO (3 male, 4 female) animals. 
Vasculature of Hippocampal Regions.  H&E stained sections of the hippocampal 
region, including the Dentate Gyrus (DG) and region CA1, were evaluated for each animal in the 
second testing cohort, for a total of 11 WT (6 male, 5 female) and 7 IL1-R1 KO (3 male, 4 
female) animals.  Images were analyzed for four vascular parameters. The median vessel 
diameter was calculated for each animal, measuring the minimal diameter (in microns) of vessels 
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cut across a transverse plane in coronal sections, indicating rostral-caudal coursing vasculature.  
In addition, the minimal diameters were determined across the width of longitudinally oriented 
vessels in the same plane, which consisted of dorsal-ventral or medial-lateral coursing vessels.  
The total number of sampled blood vessels (both transverse/coronal cut vessels and blood vessels 
running longitudinally) was calculated for each animal using point-count stereology.  In addition, 
the proportion of transverse cut vessels with visible intrusion of cells (i.e. infiltrates) within the 
lumen of the vessels was calculated for each animal.  This measure was included to look for 
possible evidence of leukocyte migration across the BBB, which has been found in several 
neurological conditions, including MS and other autoimmune disorders (see Takeshita & 
Ransohoff, 2012, for a review). 
Microglia Populations and Morphology.  Iba1 immunostained sections of the 
hippocampal region, including the Dentate Gyrus (DG) and region CA1, were evaluated for each 
animal in the second testing cohort, for a total of 12 WT (6 male, 6 female) and 10 IL1-R1 KO (5 
male, 5 female) animals. A total count of labeled microglia contained within the focal plane for 
one pseudorandomly selected focal plane in one section was calculated in each region for each 
animal using the Cell Counter Tool in Image J software.  Randomly selected high magnification 
fields of areas within both the CA1 and the DG regions within the original field were sampled 
for each animal.  Microglial cell soma areas (in squared microns) were measured for each 
animal, for all visible labeled cells within the visual field, with separate calculations for the DG 
and region CA1. 
Statistical Analyses.  Histological measures for vasculature and microglia were analyzed 
for genotype and sex differences, as well as for genotype by sex interactions using separate 
univariate ANOVA tests.  Appropriate alpha adjustments for significant testing were made to 
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accommodate for multiple testing.  In addition, all histology measures were correlated with 
behavioral test results associated with significant findings in AIMs I and II.  To test for 
correlations with depressive-type behavior, histological measures were correlated with time 
spent immobile on day two of testing, for both younger and older animal test groups.  To test for 
correlations with learning and memory performance, histological measures were correlated with 
final trial block latencies to find the hidden platform for both younger and older test groups, as 
well as the proportion of time spent in the goal quadrant during the MWM probe-trial retention 
test, again for both younger and older animals. 
Results 
Gross Anatomy and Structural Abnormalities of Hippocampal Regions 
There were no noticeable differences in gross anatomy (see Figure 21), or any differences 
in overall hippocampal structure across the different groups (see Figure 22). 
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Figure 21.  Representative samples of H&E stained coronal slice of male WT (A), female WT 
(B), male IL1-R1 KO (C), and female IL1-R1 KO (D) mouse brains. Magnification = 1X 
A B 
D C 
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Vasculature of Hippocampal Regions 
There was a significant genotype effect for the total number of blood vessels (transverse 
cut and longitudinal vessels) within the hippocampus, with WT animals having a higher overall 
vascular investment than KO animals (see Table 26 and Figures 23–24).  There were no 
significant effects of sex, nor any genotype by sex interactions for the vascular count measure.  
In addition, there were no significant main effects of genotype or sex, or significant genotype by 
sex interactions for either vessel diameter (see Table 27 and Figure 24) or the presence of 
infiltrating intravascular cells (see Table 28 and Figure 24). 
Figure 22.  Representative samples of H&E stained coronal slice of the hippocampal 
region for male WT (A), female WT (B), male IL1-R1 KO (C), and female IL1-R1 KO (D) 
mouse brains. Magnification = 5X 
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B 
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Table 26:  Total Blood Vessels per Frame 
 
 
F (df) p 
Genotype 9.121 (1, 18) 0.009* 
Sex 0.147 (1, 18) 0.708 
Genotype* x Sex 0.355 (1, 18) 0.561 
* significant at the p < .05 level 
   
Table 27:  Median Vessel Diameter 
 
 
F (df) p 
Genotype 1.863 (1, 18) 0.194 
Sex 0.808 (1, 18) 0.384 
Genotype x Sex 0.471 (1, 18) 0.504 
* significant at the p < .05 level 
   
Table 28:  Proportion of Vessels with Infiltrating Cells 
 
 
F (df) p 
Genotype 0.495 (1, 18) 0.493 
Sex 1.046 (1, 18) 0.324 
Genotype x Sex 0.004 (1, 18) 0.952 
* significant at the p < .05 level 
 
 
 
  
Figure 23.  Representative samples of vascular investment in the hippocampal region 
for WT (A) and IL1-R1 KO (B) mice. Magnification = 20X   
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Each vascular measure was tested for a significant correlation with behavioral measures 
associated with prior significant findings in AIMs 1 and 2 (see Table 29).  There was a 
significant correlation between the total number of vessels in the hippocampus and the 
proportion of time spent in the goal quadrant during the MWM retention probe trial for older 
animals (see Figure 25).  Animals with greater vascularization of the hippocampus had better 
retention for the location of the platform when tested at an older age.  When broken down by 
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Figure 24.  Mean total number of blood vessels observed in a single image taken from the 
hippocampal region of IL1-R1 KO and WT mice (A), the average median diameter of 
observed blood vessels within the same region (B), and the proportion of blood vessels 
observed in these same regions presenting with infiltrating cells (C).  n = 3–6/group. 
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genotype, the correlation of the total count of blood vessels to MWM retention performance was 
stronger for IL1-R1 KO animals [r (6) = .70)} than WT animals [r (7) = .55], though the 
difference between the two correlations was not significant (Z = 0.411, p = .681). 
There were no significant correlations between depressive-type behavior in either 
younger or older animals and any of the vascular measures (see Table 29). 
Table 29:  Correlations between Vascular Histology and Behavioral Measures 
  Microglia Measures   
Behavioral Measures 
Total  
Vessels 
Median Vessel 
Diameter 
Proportion 
Vessels with 
Infiltrating Cells 
Younger FST Immobile 
Time r (18) = .128 r (18) = .297 r (18) = -.104 
  p = .612 p = .232 p = .682 
Older FST Immobile Time r (17) = -.043 r (17) = -.226 r (17) = -.356 
  p = .870 p = .384 p = .161 
Younger MWM Final  r (18) = -.164 r (18) = -.284 r (18) = -.019 
Block Latency p = .515 p = .253 p = .941 
Younger MWM Retention r (18) = .040 r (18) = .296 r (18) = -.171 
  p = .874 p = .233 p = .498 
Older MWM Final  r (17) = .044 r (17) = .228 r (17) = -.041 
Block Latency  p = .868 p = .379 p = .875 
Older MWM Retention r (17) = .535 r (17) = .035 r (17) = -.048 
  p = .027* p = .893 p = .855 
* significant at the p < .05 level 
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Microglia Populations and Morphology 
IL1-R1 KO animals were not found to significantly differ from WT animals in the 
number of microglia in observed hippocampal sections [F (1, 22) = 1.186, p = 0.062], nor was 
there a significant effect for sex [F (1, 22) = 7.359, p = 0.290] or a significant genotype by sex 
interaction [F (1, 22) = 0.336, p = 0.569], see Figures 26–27.  The average of individual animal 
median microglia cells size in both the DG and region CA1 of the hippocampus were found not 
Figure 25.  Correlation between the proportion of time spent in the goal quadrant 
during the MWM probe retention trial and the total number of blood vessels observed 
in a coronal slice of the hippocampal region for IL1-R1 KO and WT mice.  n = 17. 
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to differ by genotype or sex, with no genotype by sex interactions (see Tables 30–31 and Figure 
28).  
Table 30:  Median Microglia Cell Body Area 
in the Dentate Gyrus     
 F (df) p 
Genotype 3.128 (1, 22) 0.094 
Sex 2.976 (1, 22) 0.102 
Genotype x Sex 0.076 (1, 22) 0.786 
* significant at the p < .05 level   
 
Table 31:  Median Microglia Cell Body Area 
in Region CA1!
 
  
 F (df) p 
Genotype 0.154 (1, 22) 0.699 
Sex 1.875 (1, 22) 0.188 
Genotype x Sex 0.851 (1, 22) 0.368 
* significant at the p < .05 level   
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Figure 26.  Representative samples of Iba1 stained microglia within the DG of WT (A), and 
IL1-R1 KO mice (B), and within region CA1 of WT (C) and KO mice (D). Magnification = 
20X   
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Each microglia measure was tested for a significant correlation with behavioral measures 
associated with prior significant findings in AIMs 1 and 2, with no significant correlations 
revealed (see Table 32). 
 
 
 
Figure 27.  Mean total count of microglia observed in a coronal slice of the 
hippocampal region of IL1-R1 KO and WT mice.  n = 5–6/group. 
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Figure 28.  Mean of median cell body size of microglia in the Dentate Gyrus (A) and 
region CA1 (B) of the hippocampus for IL1-R1 KO and WT mice. n = 5–6/group. 
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Table 32:  Correlations between Microglia Histology and Behavioral Measures 
  Microglia Measures   
Behavioral Measures 
Total 
Microglia 
CA1 Median  
Cell Size 
DG Median  
Cell Size 
Younger FST Immobile 
Time r (22) = -.195 r (22) = -.301 r (22) = -.159 
  p = .383 p = .174 p = .478 
Older FST Immobile Time r (21) = .169 r (21) = .200 r (21) = .220 
  p = .465 p = .385 p = .338 
Younger MWM Final  r (22) = .262 r (22) = -.037 r (22) = .194 
Block Latency p = .239 p = .870 p = .387 
Younger MWM Retention r (22) = .036 r (22) = -.012 r (22) = -.058 
  p = .875 p = .956 p = .797 
Older MWM Final  r (21) = .044 r (21) = .067 r (21) = .183 
Block Latency  p = .850 p = .773 p = .428 
Older MWM Retention r (21) = -.094 r (21) = .061 r (21) = -.227 
  p = .684 p = .792 p = .321 
* significant at the p < .05 level 
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Discussion 
Neuroanatomical measures revealed no gross differences in cortical size nor structure, 
nor in hippocampal structure between IL1-R1 KO mice and WT animals. However, IL1-R1 KO 
animals did have significantly reduced vascular investment in the hippocampal region, a 
difference that was found to correlate with cognitive performance in older animals.  The changes 
in vasculature were not accompanied by significant differences in microglial cell populations. 
The reduced vascularization observed in IL1-R1 KO animals may reflect the influence of 
IL-1 activity on the upregulation of vascular endothelial growth factor (VEGF), a driving force 
in angiogenesis.  IL-1β initiates angiogenesis by recruiting endothelial cells to produce VEGF, 
with then promotes the growth of new capillaries from pre-existing blood vessels (see Voronov, 
Carmi, & Apte, 2014, for a review).  Reductions in VEGF activity and associated loss or 
reduction in angiogenesis has been observed in both ischemic hindlimb injury (Amano et al., 
2004) and tumor growth (Carmi et al., 2009) studies using IL1-R1 KO animals.  Thus, it is 
possible in the current study that the lack of IL-1 activity in IL1-R1 KO animals contributed to a 
loss of normal vascular functions, including in the hippocampus. 
We specifically found decreased vascularization in region CA1 and the nearby 
hippocampal fissure that was correlated with impaired spatial learning and memory performance 
for older animals, as well as an overall impairment in learning and memory performance in older 
IL1-R1 KO animals that also had a reduced vascular presence in these regions.  Because of the 
relatively high concentration of NMDA receptors in area CA1 it is particularly susceptible to 
excitotoxic damage associated with hypoxia and ischemia of vascular disease. On the other hand, 
the DG is relatively less susceptible to vascular disease and more sensitive to corticosteroid 
changes because of a high concentration of glucocorticoid receptors.  Small and colleagues 
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(2011) propose a functional model of hippocampal circuitry in which the more vascular sensitive 
CA1 region is critical for integrating input from the entorhinal cortex and CA3, helping with the 
formation of allocentric spatial maps, and making this region critical for learning in tasks such as 
the MWM.   
Both normal aging animals and AD model animals are found to have reduced capillary 
loss and impaired angiogenesis functions, resulting in decreases in microvascular densities 
within the hippocampus.  These reductions in cerebral perfusion are consistently associated with 
degrees of impairment in dementing conditions (see Brown & Thore, 2011, for a review).  
Taking into account what is known about IL-1’s contribution to VEGF-related angiogenesis, and 
the normal age-related increase in neuroinflammation and impaired neurogenesis, the current 
study may provide evidence of IL-1 playing a protective role in the preservation of hippocampal 
function through the promotion of angiogenesis.   In the case of IL1-R1 KO animals, which 
presumably would be somewhat spared the normal age-related increase in neuroinflammation, 
but also miss out on the associated increase in VEGF-related angiogenesis.  Thus, our observed 
reduction of vascularization in the hippocampus for IL1-R1 KO animals is not surprising.  In 
addition, the significant correlation between vascular counts and impaired MWM performance is 
consistent with above-noted findings of learning and memory impairments observed in clinical 
populations with reduced hippocampal vascularization.. 
The current findings revealed no significant correlation between depressive-type behavior 
and vascular differences.  It is plausible to expect decreased vascularization in animals with 
poorer learning and memory performance, given the recognized link in vascular depressive 
conditions (e.g., Alexopolous et al., 1997).  Unlike models of vascular dementia and AD, in 
which specific changes in hippocampal vasculature have been noted, vascular depression models 
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have typically associated depressive conditions to more widespread changes in vascular 
functioning and focus on cortical and subcortical structures (Taylor et al., 2013).  Thus, by 
limiting the observation of vascular changes to post-mortem vascular count and diameter in the 
CA1 region of the hippocampus, we have failed to evaluate more global or dynamic changes in 
cerebral blood flow, and therefore cannot rule out the possibility of blood flow changes as an 
underlying factor in depressive-like behaviors based on the methods used in the current study. In 
addition, although our female KO animals exhibited depressive-like behaviors when they were 
young, they no longer showed these behaviors when they were older, which is when tissue was 
collected. 
Finally, the current study failed to reveal significant differences in either the number or 
size of microglia for IL1-R1 KO versus WT animals.  It is important to note the Iba1 stain does 
not specifically label activated microglia.  However, morphological changes in microglia shape 
and size have previously been validated as a measure for recognizing microglia activation 
following LPS injections (Kozlowski & Weimer, 2012).  The finding of no genotype effect in the 
soma size for microglia is unexpected, as prior research has indicated that IL1 plays an important 
role in neuroimmune activity, including the activation of microglia (e.g., Chung et al., 2010).  In 
addition, since increases in IL-1 activity are associated with increases in activated microglia, 
especially for aged populations (Bay-Richter et al., 2011; Dilger & Johnson, 2008), there is the 
possibility that the impaired IL-1 activity in IL1-R1KO animals would protect them from typical 
age-related increases in activated microglia.  However, the protective effects of a reduction in IL-
1 activity may only be observable with an additional stressor or pathogen that increases 
neuroinflammation in WT mice but possibly sparing IL1-R1 KO mice.  This possibility has been 
tested previously with very young (25-30 day-old) male IL1-R1 KO mice, which also revealed 
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no genotype effects in the presence of activated microglia within the hippocampus following 
LPS injections (Harry et al., 2008).  This does not rule out the possibility an effect could be 
found with older animals.   It should also be noted, the current study was limited to testing a 
small sample for the histology measures (only one cohort), This, along with the high degree of 
heterogeneity of behavioral testing in older animals, may have reduced power levels enough to 
prevent reaching significance for both tests of differences in genotypes and neurobehavioral 
correlates. In addition, IL1-R1 KO animals have a deficiency specific to IL-1 activity, leaving 
the possibility for compensatory actions associated with other cytokines, such as IL-6 and TNF-
α.  In fact, Bluthé et al. (2000) have previously shown TNF-α can replace IL-1 in IL1-R1 KO 
mice following an LPS injection.   Finally, in the current study we only evaluated microglial size 
and investment, and so cannot rule out the possibility that differences in microglial function were 
present and contributed to behavioral effects. 
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CHAPTER 6:  GENERAL DISCUSSION 
IL1-R1 KO animals were tested across a wide range of behavioral tests at two different 
ages.  The most prominent behavioral finding was a sex-specific impairment in spatial learning 
and memory performance such that IL1-R1 KO males were significantly impaired in MWM 
acquisition and retention relative to either female KO animals or WT animals of either sex.  
More minor changes in emotional processing, including anxiety and depressive-type responses, 
were observed, and findings of mild increases in depressive and anxious-like behaviors were 
only present in female KOs, suggesting a different profile of behavioral impairments in male 
versus female KO mice.  In addition, although the brains of IL1-R1 KO animals were grossly 
normal, they were found to have reduced hippocampal vasculature, which was significantly 
correlated with the observed cognitive abnormalities. 
The Importance of IL-1 Activity for Cognitive Behavior 
Previously, the link between IL-1 activity and learning and memory performance in 
human research and clinical populations has been mixed, in part due to differences in research 
protocols and limitations in experimental control (Vollmer-Conna et al., 2004).  However, the 
overall pattern has shown that increased cytokine activity, including increased IL-1, is linked to 
impairments in cognitive performance.  Increased levels of circulating IL-1β in patients with AD 
and in healthy individuals exposed to an acute stressor have been linked to impaired performance 
across multiple cognitive tasks (Forlenza et al., 2009; Krabbe et al., 2005).  Research with 
animals has helped to more clearly establish the link between IL-1 activity and changes in 
cognitive function, suggesting an optimal level of IL-1 activity is critical for normal 
hippocampal-dependent spatial learning and memory functions.  Rather than just the mere 
presence or absence of IL-1, Gibertini (1998) proposes that either abnormally high or low levels 
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of IL-1 activity can have a negative impact on hippocampal function.  For example, animals 
injected with the bacterial component lipopolysaccharide (LPS) had an increase in IL-1 activity 
that directly corresponded to decreases in MWM learning performance (Oitzl et al., 1993).  
While Murray et al. (2013) found no impairments in MWM performance for female IL1-R1 KO 
animals, Avital et al. (2003) found male IL1-R1 KO mice had impaired learning performance in 
the MWM (Avital et al., 2003).  These MWM effects are specific to hippocampally-mediated 
spatial learning and memory performance, while non-spatial performance is typically spared 
(Moore et al., 2009; Avital et al., 2003; Murray et al., 2013).  Increased cytokine activity, 
whether stress-induced, age-related, or triggered by the introduction of a pathogen, has been 
linked to impaired hippocampal learning mechanisms, including reductions in neurogenesis and 
LTP processes, especially in the CA1 region (Oitzl et al., 1993; Koo & Duman, 2008; Ross et al., 
2003; Chugh et al., 2013; Murray & Lynch, 1998).  In addition, IL-1 specifically has been 
identified as important in the upregulation of VEGF-related angiogenesis (Amano et al., 2004).  
The angiogenic influence of VEGF within the hippocampus is also associated with hippocampal 
neurogenesis (see Ruiz de Almodovar, Lambrechts, Mazzone, & Carmeliet, 2009, for a review).  
Thus, it is possible the current findings related to impaired spatial learning and memory, as well 
as depressive-type behaviors in IL1-R1 KO mice may reflect an impact on VEGF-related 
angiogenesis within the hippocampus.  This theory is also supported by our finding of a 
significant correlation between reduced vasculature in the hippocampus and poorer MWM 
retention performance in older animals. 
The current study further supports the theory that normal IL-1 signaling is necessary for 
optimal hippocampally-mediated spatial learning and memory functions, as male IL1-R1 KO 
animals were impaired in the acquisition and retention of a hidden platform in the MWM.  The 
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difference between groups was stronger at the younger testing age, and was only present in the 
male animals.  In fact, at the older age of testing, overall learning performance differences were 
statistically attenuated by the increase in behavioral variability that is typical with aging animals 
(van der Staay, 2002).  Poor memory retention in the MWM could simply reflect a failure of 
learning, because memory for a task cannot be retained if it is never acquired.  The finding of a 
stronger impairment in learning and memory performance for male IL1-R1 KO animals when 
compared to female IL1-R1 KO animals is a novel, though Murray et al. (2013) also found no 
impairment in MWM performance in testing with only female IL1-R1 KO animals.  The 
mechanism underlying the preservation of learning in female IL1-R1 KO mice is unknown, but 
could reflect a protective function of ovarian hormones in the hippocampus, preventing acute and 
chronic stress-related anti-neurogenesis (Falconer & Galea, 2003; Westenbroek et al., 2004).  It 
is also possible that the female KOs had an increased motivation to solve the maze task because 
of their mildly elevated anxiety.  This explanation seems unlikely, however, given their tendency 
toward learned helplessness in the FST, which would be counterproductive in the MWM task. 
Generally, the current findings are consistent with prior research indicating that an 
optimal level of IL-1 activity is required for optimal spatial learning and memory functions. 
Although the mechanisms underlying the impairment in learning are unknown, the finding of a 
significant correlation between learning performance and vascular investment suggests that 
impaired hippocampal perfusion could have been a contributory or related factor.  More work 
will need to be done to determine whether the relationship between learning and vascular 
investment in these mice is causal or merely correlational.  In addition, studies of the vasculature 
in developing IL1-R1 KO mice would help to answer the question of whether the IL-1 signaling 
deficiency leads to poor vascular development or a failure of later sprouting, compensatory 
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vascular enrichment, or vascular retention, and the possible role of VEGF in helping to regulate 
these processes 
The Importance of IL-1 Activity for Emotional Behavior 
In addition, to learning, IL-1 activity has also been linked to stress responses and anxiety. 
These links have primarily been described in research conducted with endogenous increases in 
cytokine activity.  For example, in one study, healthy young adults were exposed to a cognitive 
stressor. Those who reported the greatest increase in feelings of anxiety also had the greatest 
changes in circulating IL-1β levels (Maes et al., 1998).  Similar findings have been described 
with clinical populations who have atypically strong increases in IL-1β activity in response to 
environmental stressors and report associated feelings of overwhelming anxiety, such as in 
patients with PTSD (Spivak et al, 1997).  In addition, animal research into anxiety-related 
behaviors, focusing on approach and exploratory drives, have found that increased IL-1β levels 
are associated with increased anxiety-like behaviors, such as a reduced exploratory drive and 
neophobia (e.g., Swiergiel & Dunn, 2007).  Conversely, male IL1-R1 KO animals have been 
noted to have a reduction in anxiety-type behaviors when exposed to a series of chronic stressors 
(Koo and Duman, 2009), a finding that we have not replicated at a statistically significant level.  
Indeed, while we never observe significant decreases in anxiety-related behaviors in our male 
IL1-R1 KO animals, we do observe that their mean scores are always lower than those of their 
WT counterparts in measures of anxiety-like behaviors (i.e. light-dark task, elevated plus maze, 
open field center square). 
Despite the consistent finding of a link between anxiety and IL-1 activity, the relationship 
between neuroinflammatory mechanisms and the stress response is highly complex.  There are 
differences in the presence and strength of effects for different types of stressors, the duration of 
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a stressor, and the different types of behavioral test measures (Murray & Lynch, 1998; Plata-
Salamán et al., 2000; Badowska-Szalewska et al., 2009).  Similarly, the findings in the current 
study were mixed.  Although a reduction in anxiety-type behaviors was observed for male IL1-
R1 KO animals in the open field test and novelty-suppressed feeding test, the female animals do 
not show a similar pattern of anxiety-related behaviors.  For example, while female IL1-R1 KO 
animals were similar to their male counterparts in having a reduced anxiety response in the open 
field test, they were more like WT male animals in the novelty-suppressed feeding test. In 
addition, neither male nor female IL1-R1 KO animals differed from WT animals in the light-
dark test.  Thus, the current findings, while generally consistent with prior findings of a reduced 
anxiety response in male IL1-R1 KO animals, further complicate understanding the role of IL-1 
in anxiety-related behaviors.  It is possible IL1-R1 KO males have an accelerated decline in 
anxiety-related behaviors that are observable in younger animals, while females may be delayed 
or experience a more gradual decline associated with decreased hippocampal efficiency.  But this 
interpretation is limited given Murray et al. (2013) were able to find reduced anxiety-type 
behaviors in young adult female IL1-R1 KO animals in the elevated plus maze.   Also important, 
the current battery of tests did not directly test the difference between chronic and acute 
stressors, which are also known to vary in their effects across different ages and by sex 
(Badowska-Szalewska et al, 2009; Yee & Prendergast, 2010). 
Researchers originally explored the link between depressive conditions and IL-1 in the 
1950s, studying increases in cytokine activity and related sickness behavior, including loss of 
appetite, feelings of malaise, and social withdrawal (see Dantzer & Kelly, 2007, for a review).  A 
half-century later, with the development of new behavioral testing paradigms and antidepressant 
medication, research began to take a closer look at the potential relationship between IL-1 
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activity and depression (Yirmiya et al., 1999).  In fact, people with cytokine-related illnesses will 
often report feelings of depression (e.g. Whalley et al., 2007), and some individuals diagnosed 
with clinical depressive conditions with no comorbid medical conditions have also been found to 
have increased inflammatory activity (e.g., Owen et al., 2001). 
However, depressive conditions are distinct from a sickness behavioral response, but 
happen to share underlying related symptomatology and links to changes in neuroinflammation 
and stress-related changes in HPA axis activation.  For example, IL-1 activity has been shown to 
be critical for the development of anhedonic-type behaviors following chronic stress exposure 
(Koo & Duman, 2008).  However, in more traditional learned-helplessness models of depressive 
behavior testing, the findings have been inconsistent.  In one set of studies IL-1 activity was 
found to be critical for the development of a depressive-type response to a painful stressor 
(Maier & Watkins, 1995), while Koo and Duman (2009) found IL1-R1 KO mice did not differ 
from WT animals in depressive-type behavior during the FST.  Similar to Koo and Duman, the 
young male IL1-R1 KO animals did not differ from their young male WT counterparts in the 
FST.  However, the inclusion of females in the current study revealed an increase in depressive-
type behaviors for female IL1-R1 KO animals, but only at the younger age of testing.  The link 
between a loss of normal IL-1 activity in IL1-R1 female KO mice and an increase in depressive-
type behavior in the FST is unclear, especially given prior findings that female rats injected with 
LPS leading to an enhanced HPA axis response also had a decrease in depressive-type behavior 
in the FST (Pitychoutis et al., 2009).  These researchers also noted an increase in serotonin 
activity, and suggested a sex-specific coping style that results in reductions depressive-type 
behavior. 
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In addition, there is a general concern regarding factors that may influence FST 
behaviors, including species, sex, and strain differences.  For example, rats typically require two 
training episodes before developing an immobility response during the test phase of the test, 
while mice require only one training episode (see Bogdanova, Kanekar, D’Anci, & Renshaw, 
2013, for a review).  Also, female rats have been shown to be more sensitive to picking up a 
depressive-type response to the FST than male rats (Dalla, Pitychoutis, Kokras, & 
Popadopoulou-Daidfoti, 2011), while others have found sex-differences among mice to be strain-
dependent (see Petit-Demouliere, Chenu, & Bourin, 2005, for a review).  Thus, our findings of a 
sex-based difference in a mutant mouse strain may not be comparable to prior research 
conducted in rats.  Finally, extensive research has found a high degree of variability across 
different mouse strains in the development of a depressive-type response in the FST (see Cryan 
& Mombereau, 2004, for a review).  The C57/BL6 mouse strain we tested is known to have a 
moderate to strong responsiveness to this test, but have failed to specifically compare male and 
female animals (e.g., Matsuo et al., 2010). Therefore, the interpretation of our findings is limited 
and requires further exploration with both WT and KO animals. 
FST findings are often subject to scrutiny, as researchers have proposed different 
explanations for immobility and reductions in escape behaviors (see O’Leary & Cryan, 2013, for 
a review).  Originally, Porsolt (as cited in O’Leary & Cryan) viewed immobility as evidence of 
“behavioral despair”, indicating an inability or failure to engage in persistent escape-related 
behaviors.  Others propose immobility reflects a switch from an active to passive coping strategy 
to dealing with an immediate stressor (Holmes, Yang, Murphy, & Crawley, 2002), which may 
even have an evolutionary advantage in preserving energy for an extended exposure to a stressor.  
Finally, there is also the possibility increased mobility reflects an overall reduction in swimming 
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behavior, reflecting an impairment in locomotor function.  Our findings rule out this last 
interpretation, as both female and male KO animals were not found to differ in their exploration 
of the open field apparatus, and had no apparent apraxia-type abnormalities in the gait test. 
The link between neuroinflammation, cerebrovascular function, and depression are even 
more apparent in older-aged populations who are particularly susceptible to vascular depression.  
In this case, age-related changes in cerebrovasculature, including a leaky BBB and general 
impairments in cerebral blood flow, are thought to contribute to a widespread impairment of 
networks connecting cortical and subcortical structures, including the hippocampus and 
entorhinal cortex, contributing to the development of a depressive condition (Taylor et al., 2013).  
The current finding failed to find age-related differences in depressive behavior for IL1-R1 KO 
animals.  However, animals with the strongest depressive-type response during the older age of 
testing on the FST were found to have a decreased vascular investment in the hippocampus.  
This relationship between depressive behavior and vasculature was not found for younger 
animals, consistent with an age-related change in vasculature that correlates with a depressive-
type profile in older animals. 
The IL1-R1 KO Mouse Phenotype 
Besides the noted sex- and age-specific changes in spatial learning and memory function, 
anxiety behaviors, and depressive-type behavior, IL1-R1 KO animals had generally intact 
behavioral and morphogenic traits.  Their locomotor behavior was within a normal range on tests 
of gross motor activity and gait.  IL1-R1 KO animals were found to have significantly smaller 
sized eyes, but had showed no deficit in a standard rodent test of ability to use depth perception 
to guide behavior, suggesting that they were not blind as a consequence.  They also showed a 
statistical trend toward a difference in philtrum length, but no other notable changes to facial 
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morphology.  The observed differences potentially reflect the importance of IL-1 in normal 
neurodevelopment processes, including bone growth (MacRae et al., 2007).  It is not uncommon 
for children with developmental disabilities to show striking or subtle differences in facial 
morphology, including smaller eyes and increased philtrum length (e.g., Korenberg et al., 1994). 
While differences were observed in novelty approach and exploratory behaviors, as 
discussed above in the section on anxiety, these mice were not directly tested on measures of 
trait anxiety.  This trait could be meaningful, as Jakovcevski, Schachner, and Morellini (2008) 
found that this strain of mouse (C57BL/J6) is prone to have higher levels of trait anxiety, which 
may have impacted test performance.  Finally, IL1-R1 KO animals were not found to differ from 
WT animals in a measure of social interactions.  This finding is inconsistent with the findings of 
Bison et al. (2009) who noted reduced social interactions in rats injected with LPS, although they 
also observed decreases in locomotor function and other behaviors consistent with a sickness 
behavior response to increased cytokine activity.  Thus, social interaction test performance may 
not be dependent on IL-1 activity, per se, but a more extreme sickness profile that could involve 
multiple inflammatory mediators.  The IL-1R1 KO animals have a very specific deficit in IL-1 
signaling, and are therefore missing many components of the response induced by LPS.  Our 
results with animals tested at an older age may have been better indicators of any role of IL-1 in 
pathological-type behaviors, because young animals normally do not have as much 
neuroinflammation at baseline as older animals.  Age-related increases in neuroinflammatory 
drive could be reduced for IL1-R1 KO animals relative to aging WTs, making them less prone to 
chronic stressors that are also associated with changes in social interaction behavior, especially 
for male mice (Yee & Prendergast, 2010). 
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Limitations 
The current study employed the use of a KO mouse model, with behavioral tests that 
were conducted across different ages, and in some case repeatedly tested with the same animals.  
Given the nature of this research design, there are inherent limitations to the interpretation of the 
research findings. 
Behavioral testing was conducted between the ages of 2 and 13 months of age, with 
animal sacrifices at approximately 14 months of age.  We only observed brains of older animals 
and cannot ascertain if differences in neuroanatomy were present at younger ages.  This is 
especially important for the interpretation of behavioral findings with younger animals. 
Targeted gene modifications in animals play an important role in biomedical research, 
allowing for the association of specific gene deficits with sets of behavioral outcomes. In the 
case of the IL1-R1 KO mouse there is a targeted mutation that produces a strain of mouse that is 
null for the production of a functional type I IL-1 receptor and therefore fails to have a normal 
IL-1 component of the immune response (Glaccum et al., 1997).  In the current study, adult KO 
mice were compared to a set of age-matched WT animals from the same genetic background 
strain, with behavioral differences attributed to the alteration of IL1-R1 activity.  However, this 
interpretation must be further evaluated.  For example, it has been previously established that one 
major complication with KO or knock-in genetic alterations is the possibility for the unintended 
effects of “flanking genes” associated with genetic backcrossing (see Eisener-Dorman, 
Lawrence, & Bolivar, 2009, for a review). 
During the process of isolating a gene for removal, a nonfunctional gene is often 
introduced to take the place of the targeted gene (Doyle, McGarry, Lee, & Lee, 2012).  The 
process requires the introduction of additional background material, which is later targeted for 
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removal during subsequent selective breeding process, with the ultimate goal of producing a 
mutant mouse strain that is identical to the original WT strain with the exception of the targeted 
gene.  However, there is rarely complete removal of all of the background material, which can 
affect neighboring genes, with the known potential to wholly or partially affect phenotype 
measures.  For example, Rodrigues de Ledesma, Desaie, Bolivar, Symulu, and Faherty (2006) 
were able to determine flanking genes instead of the targeted null gene were responsible for a 
phenotype of reduced exploratory behavior in the B6-IL-10 KO mouse, null for IL-10 activity.  
The IL1-R1 KO mouse is classified as an incipient congenic strain, reflecting an attempt to 
reduce the potential for flanking genes through a specific process of inbreeding, but cannot rule 
out the presence of non-targeted genetic influences (The Jackson Laboratory, 2014).   
Even if mutations of a specific gene can be limited in a KO animal model, there is still an 
inherent hazard regarding the outcome of behavioral data in adult animals from a targeted null 
mutation.  When evaluating data from adult animals, there is a temptation to assume the 
differences between KO and WT animals at the time of testing is directly related to the loss of 
the gene’s function in the animal at the time of testing.  For example, in the current study there is 
the primary interpretation that differences in performance reflect differences in IL-1 activity in 
the adult animal, with less consideration of the potential impact of the loss of a normal IL1-R1 
system in the development of the animal.  In fact, IL-1 is known to have a widespread influence, 
both in the development of muscular and skeletal systems (Alexander, Murgai, Moehle, & 
Owens, 2012; MacRae et al., 2007), as well as in prenatal cortical cell migration (Ma et al., 
2014).  In addition, IL-1 plays an important role in a very complex immune system that is highly 
adaptable, making it likely compensatory developmental mechanisms could occur to adjust for 
the reduction in normal IL-1 activity in the KO mouse.  Thus, it would be ideal to compare these 
  
129 
129 
animals to animals with a normal developmental path with IL1-R1 inactivated in the adult 
animal.  The use of IL-1ra has been explored previously in research of IL-1 activity in rats (e.g., 
Koo & Duman, 2008) and been helpful in studying changes in behavior associated with the 
blocking of IL-1 activity with the introduction of a pathogen or chronic stressor (e.g., Yirmaya et 
al., 2002).  The recent development of IL-1 Trap (Rilonacept) offers another method for 
inhibiting IL-1 activity in an intact adult system.  IL-1 Trap acts as a soluble decoy receptor, with 
a very high affinity to bind to both IL-1α and IL-1β, preventing the activation of intact IL-1 
receptors (Economides et al., 2002).  IL-1 Trap has been found to be effective in the significant 
reduction of systematic inflammation and associated symptoms, including joint pain and fatigue 
(Hoffman et al., 2012).  However, to date no studies have looked at cognitive behavior and the 
use of IL-1 Trap in either clinical or animal research applications.   
Besides concerns with interpreting the effects of gene deletion using a KO animal model, 
the current study has the expected limitations of longitudinal research, including the potential for 
carryover effects, including learning, across different behavioral tests and also repeated exposure 
to a single behavioral test.  For example, both the MWM and the FST involve swimming 
behavior.  While water-based testing was always separated by at least 8 weeks to try to minimize 
carryover, the sequencing of testing and the frequency of testing differed for the two cohorts, 
with one cohort’s first swim test being in the FST and the other cohort initially tested in the 
MWM.  Thus, for the cohort that was originally tested in the FST and had developed a learned-
helplessness type response in the water, helplessness may have inhibited their swimming 
performance in the MWM.  Likewise, animals that failed to find the platform on early training in 
the MWM may have developed a learned-helplessness type response to water, affecting the 
magnitude of their later response to the FST.  The sequence was intentionally reversed across the 
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cohorts to try to balance any potential carryover effects.  However, the finding of a significant 
cohort effect for the younger animals in the FST could reflect such carryover effects, as the 
cohort found to have a greater learned-helplessness type response in the FST was the same 
cohort that had been previously tested in the MWM.  The fact that the females had successfully 
learned the MWM task, and were the sex showing learned helplessness argues against amplified 
helplessness, but other emotional or learning-related factors could still have contributed. 
Potential learning effects may have also contributed to any noted differences in 
behavioral tests administered a second time at an older age.  Thus, when tested at an older age in 
the MWM, animals already had prior experience and may have applied a previously learned 
strategy to search for the platform in a manner that may have put them at a particular advantage 
or disadvantage at the later age of testing.  Attempts were made to reduce the effects of prior 
learning, such as moving the platform to a different goal quadrant in the apparatus when testing 
older animals.  In addition, experimental controls were maintained to allow for equal advantage 
across all animals, such as maintaining the locations of experiments and spatial cues within the 
MWM environments for both cohorts across the younger and older testing sessions.  In fact, all 
groups were found to be equivalent in their latency to find the platform in the first trial of the 
older aged round of testing, suggesting no genotype or sex differences in any carryover of 
learning from the younger testing trials. We cannot, however, exclude the possibility of a more 
delayed or gradual advantage of prior learning on the overall learning of platform location in the 
older MWM test. 
While controls were put in place to avoid experimenter effects, including the inclusion of 
blind test administrators and scorers, and the same experimenters testing all animals for a 
particular test with each cohort, other factors may have had an influence.  Only one experimenter 
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was available for testing both cohorts, with a different set of assistant experimenters for each 
cohort.  Thus, this could have contributed to any observed cohort effects.  In addition, the sex of 
experimenters was not controlled, with a mix of male and female experimenters for different 
behavioral tests.  Recently, it has been noted mice may respond differently to male and female 
experimenters, with a heightened stress response when handled by men (Sorge et al., 2014).  
Lastly, spatial learning in the MWM is enhanced by the ability to use visual spatial cues, 
and we cannot rule out the possibility of preferentially impaired vision for the IL1-R1 KO 
animals. While KO animals were not found to differ from WT animals on a gross measure of 
depth perception, they did have slightly smaller eyes.  However, given that mice rely heavily on 
non-visual spatial cues, and that most inbred mice have poor vision by middle age in any case, it 
is unlikely any potential visual impairment had any significant impact on maze performance.  It 
is important to note that both male and female KO animals had small eyes, yet only the males 
were found to have significant learning impairments in the MWM at a young age. 
General Conclusion and Future Directions 
The current study provides a behavioral phenotype for the IL1-R1 KO mouse, revealing a pattern 
of changes in cognitive and emotional behaviors that vary with age and by sex.  Overall effects 
of impaired spatial learning and memory performance were observed, but were primarily driven 
by very poor performance for male IL1-R1 KO mice.  In addition, reduced anxiety effects were 
observed, again stronger for male than female animals.  These findings are important in 
understanding the impact of IL-1, and the neuroimmunological system as a whole on normal 
cognitive and emotional functioning.  The findings also elucidate the importance of the inclusion 
of female animals in animal research, with sex-based differences that may reflect both biological 
and environmental factors that differentially effect vulnerability to the development of cognitive 
and emotional disorders.  The current study is also potentially illuminating for understanding the 
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impact of IL-1 in aging populations, in which neuroinflammation is a known concern and is 
often associated with cerebrovascular disease, vascular depression, and Alzheimer’s disease.  
Future research should focus in on the observed sex and genotype effects in IL1-R1 KO animals, 
and the potential interaction of these two factors, particularly exploring different models of 
depression and anxiety and looking into differences that may be observed for acute versus 
chronic stressors.  Given the potential for age and sex to play a role, these data provide some 
rationale for exploring possibilities for a protective function of moderate levels of IL-1 activity in 
the regulation emotional behaviors, and/or sex-related hormones that may help to prevent the 
cognitive and emotional impairments associated with normal aging, Alzheimer’s disease, and 
vascular depression.  
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Appendix B 
Animal Ages for Each Behavioral Test 
 
Animal ages at times of testing for behavioral tests reviewed in AIM 1 and AIM 2.  Tests 
administered at two different ages for AIM 2 are listed in table as Time 1 (younger animals) and 
Time 2 (older animals). 
  Age (in months) 
Behavioral Test Cohort 1 Cohort 2 
Elevated Plus Maze 5 11 
Facial Morphometrics - 2 
Gait 5 2 
Light-Dark Exploration (younger) 5 4 
Light-Dark Exploration (older) 12 - 
MWM (younger) 3 5 
MWM (older) 12 11 
Novelty-Suppressed Feeding 13 - 
Object Placement 13 11 
Open Field 13 11 
FST (younger) 5 2 
FST (older) - 13 
Social Interaction 7 - 
Visual Cliff 7 5 
Y-Maze - 6 
- test not administered     
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